Press Releases shown on Homepage issued by the Helmholtz Association and its Helmholtz Research CentresHelmholtz-Associationhttp://www.helmholtz.de/atom10/en/press/press_releases/?tx_a21feeds_pi1%5Buid%5D=17&cHash=e63839089e2421d4805ec1eb046c07b92013-01-12T12:43:41+01:00Thomas Gazligpresse@helmholtz.dehttp://www.helmholtz.de/uploads/tx_a21feeds/HG_LOGO_HELMHOLTZ_140x55_05.gifhttp://www.helmholtz.de/uploads/tx_a21feeds/tx_libfeedcreator2013-01-11T13:30:00+01:002013-01-11T13:30:00+01:00http://www.fz-juelich.de/SharedDocs/Pressemitteilungen/UK/EN/2013/13-01-10HGF.htmlHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Jülich, 10 January 2013 – The physicist Dr. Craig D. Roberts from Argonne National Laboratory, USA, has received the Helmholtz International Fellow Award. This prize worth € 20,000 is awarded by the Helmholtz Association and gives winners an opportunity to organize flexible research stays at one or more Helmholtz centres. Craig D. Roberts is planning to conduct research at the interface of nuclear and particle physics at Forschungszentrum Jülich's Nuclear Physics Institute (IKP) and Institute for Advanced Simulation (IAS). The 50-year-old senior physicist heads the Theory Group at Argonne National Laboratory and is among the most cited nuclear physicists worldwide. He has been cooperating closely with IKP for a number of years, and since 2010, has spent several weeks at Jülich each year as a visiting scientist. The award for Craig D. Roberts also strengthens the new Forces and Matter Experiments section of the Jülich Aachen Research Alliance (JARA-FAME).

Jülich, 10 January 2013 – The physicist Dr. Craig D. Roberts from Argonne National Laboratory, USA, has received the Helmholtz International Fellow Award. This prize worth € 20,000 is awarded by the Helmholtz Association and gives winners an opportunity to organize flexible research stays at one or more Helmholtz centres. Craig D. Roberts is planning to conduct research at the interface of nuclear and particle physics at Forschungszentrum Jülich's Nuclear Physics Institute (IKP) and Institute for Advanced Simulation (IAS). The 50-year-old senior physicist heads the Theory Group at Argonne National Laboratory and is among the most cited nuclear physicists worldwide. He has been cooperating closely with IKP for a number of years, and since 2010, has spent several weeks at Jülich each year as a visiting scientist. The award for Craig D. Roberts also strengthens the new Forces and Matter Experiments section of the Jülich Aachen Research Alliance (JARA-FAME).2013-01-10T13:00:00+01:002013-01-10T13:00:00+01:00http://www.fz-juelich.de/SharedDocs/Pressemitteilungen/UK/EN/2013/13-01-09CLIB.htmlHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Bielefeld/Dortmund/Düsseldorf/Jülich, 9 January 2013 – Funding has been renewed for the CLIB Graduate Cluster Industrial Biotechnology (CLIB-GC), which was launched in 2009 by Bielefeld University, TU Dortmund University, Heinrich Heine University Düsseldorf and Forschungszentrum Jülich. The cluster will receive funding for a further three years from the Ministry of Innovation, Science and Research of the State of North Rhine-Westphalia as well as from the universities involved.

Bielefeld/Dortmund/Düsseldorf/Jülich, 9 January 2013 – Funding has been renewed for the CLIB Graduate Cluster Industrial Biotechnology (CLIB-GC), which was launched in 2009 by Bielefeld University, TU Dortmund University, Heinrich Heine University Düsseldorf and Forschungszentrum Jülich. The cluster will receive funding for a further three years from the Ministry of Innovation, Science and Research of the State of North Rhine-Westphalia as well as from the universities involved.2013-01-09T16:02:00+01:002013-01-09T16:02:00+01:00http://www.dkfz.de/en/presse/pressemitteilungen/2013/dkfz-pm-13-02-Award-Winning-Research-for-the-Patient.phpHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

The jury at the German Cancer Research Center (DKFZ) chose two outstanding young researchers, Matthias Eder and Mathias Heikenwälder, whose research findings can be directly translated into clinical practice.

The jury at the German Cancer Research Center (DKFZ) chose two outstanding young researchers, Matthias Eder and Mathias Heikenwälder, whose research findings can be directly translated into clinical practice.2013-01-09T13:30:00+01:002013-01-09T13:30:00+01:00http://www.helmholtz-hzi.de/en/news_events/news/view/article/complete/award_for_indian_hzi_researcher/Helmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Singh Chhatwal receives Pravasi Bharatiya Samman Award 2013. In Kochi, India, the HZI scientist Prof Gursharan Singh Chhatwal was honoured today with the Pravasi Bharatiya Samman Award 2013. With this award, the Indian government dignifies the merits non-resident Indians that have helped to improve the international reputation of India. Chhatwal has continually rendered outstanding services to the Indo-German scientific cooperation. The award was ...

Singh Chhatwal receives Pravasi Bharatiya Samman Award 2013. In Kochi, India, the HZI scientist Prof Gursharan Singh Chhatwal was honoured today with the Pravasi Bharatiya Samman Award 2013. With this award, the Indian government dignifies the merits non-resident Indians that have helped to improve the international reputation of India. Chhatwal has continually rendered outstanding services to the Indo-German scientific cooperation. The award was ...2013-01-09T13:17:00+01:002013-01-09T13:17:00+01:00http://www.dkfz.de/en/presse/pressemitteilungen/2013/dkfz-pm-13-02c-Scientists-Generate-Oncolytic-Viruses-for-Targeted-Attack-on-Cancer-Stem-Cells.phpHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Researchers from the Paul Ehrlich Institute (PEI) have been the first to generate oncolytic viruses which specifically infect and kill CD133-positive cancer stem cells. Using such viruses, scientists at the German Cancer Research Center (DKFZ) and the National Center for Tumor Diseases (NCT) Heidelberg were able to substantially reduce tumor growth in cell cultures and in an animal model. Cancer Research reports on these research results in its online edition of January 4, 2013.

Researchers from the Paul Ehrlich Institute (PEI) have been the first to generate oncolytic viruses which specifically infect and kill CD133-positive cancer stem cells. Using such viruses, scientists at the German Cancer Research Center (DKFZ) and the National Center for Tumor Diseases (NCT) Heidelberg were able to substantially reduce tumor growth in cell cultures and in an animal model. Cancer Research reports on these research results in its online edition of January 4, 2013.2013-01-08T17:50:00+01:002013-01-08T17:50:00+01:00http://www.dlr.de/dlr/presse/en/desktopdefault.aspx/tabid-10172/213_read-5990/Helmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

For 205 days in 2011, Jens Titze, Professor of Electrolyte and Circulatory Research at the University of Erlangen-Nuremberg, and his team strictly controlled the diet for the Mars500 test subjects during their virtual flight to Mars. Sometimes the selected food contained a lot of salt, sometimes very little. The unexpected result of the longest sodium metabolism study to date was that the assumption that the human body would excrete the salt within 24 hours was incorrect. Instead, the human body stores salt for much longer before releasing it – an important discovery for medical research and patient care.

For 205 days in 2011, Jens Titze, Professor of Electrolyte and Circulatory Research at the University of Erlangen-Nuremberg, and his team strictly controlled the diet for the Mars500 test subjects during their virtual flight to Mars. Sometimes the selected food contained a lot of salt, sometimes very little. The unexpected result of the longest sodium metabolism study to date was that the assumption that the human body would excrete the salt within 24 hours was incorrect. Instead, the human body stores salt for much longer before releasing it – an important discovery for medical research and patient care.2013-01-08T00:00:00+01:002013-01-08T00:00:00+01:00http://www.kit.edu/visit/pi_2013_12446.phpHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Information from former times survived centuries on stone and paper. Modern hard disks, DVDs, and magnetic tapes are less stable and lose reliability after a few years already. However, they are used for the storage of data that have been gathered by modern research projects funded by millions of Euros. In the “Alliance for Research Data Storage” established in the beginning of this year, computer scientists of KIT develop strategies to overcome this dilemma in cooperation with colleagues from Cologne and Göttingen.

Information from former times survived centuries on stone and paper. Modern hard disks, DVDs, and magnetic tapes are less stable and lose reliability after a few years already. However, they are used for the storage of data that have been gathered by modern research projects funded by millions of Euros. In the “Alliance for Research Data Storage” established in the beginning of this year, computer scientists of KIT develop strategies to overcome this dilemma in cooperation with colleagues from Cologne and Göttingen.2013-01-07T00:00:00+01:002013-01-07T00:00:00+01:00http://www.kit.edu/visit/pi_2013_12443.phpHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

In the case of earthquakes, only seconds may remain for a safe escape from buildings. Debris falling down and obstructing the escape routes may even aggravate the situation. A product developed at Karlsruhe Institute of Technology (KIT) extends the time for saving lifes by reinforcing walls and keeping off the debris. An innovative building material manufacturer now has launched the mature innovation on the market.

In the case of earthquakes, only seconds may remain for a safe escape from buildings. Debris falling down and obstructing the escape routes may even aggravate the situation. A product developed at Karlsruhe Institute of Technology (KIT) extends the time for saving lifes by reinforcing walls and keeping off the debris. An innovative building material manufacturer now has launched the mature innovation on the market.2013-01-04T00:00:00+01:002013-01-04T00:00:00+01:00http://www.kit.edu/visit/12436_12442.phpHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

An efficient, robust, and compact wind power plant with a 10 MW superconducting generator is being developed by partners from industry and science within the recently established EU project SUPRAPOWER. Superconduction enables considerable savings of energy and raw materials. Within SUPRAPOWER, researchers at KIT’s Institute for Technical Physics (ITEP) develop a rotating cryostat cooling the superconducting coils down to minus 253°C - a temperature crucial for electric current flow without resistance.

An efficient, robust, and compact wind power plant with a 10 MW superconducting generator is being developed by partners from industry and science within the recently established EU project SUPRAPOWER. Superconduction enables considerable savings of energy and raw materials. Within SUPRAPOWER, researchers at KIT’s Institute for Technical Physics (ITEP) develop a rotating cryostat cooling the superconducting coils down to minus 253°C - a temperature crucial for electric current flow without resistance.2013-01-03T11:27:00+01:002013-01-03T11:27:00+01:00http://www.dkfz.de/en/presse/pressemitteilungen/2013/dkfz-pm-13-01-A-Shield-Against-Cancer.phpHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Tumors grow more rapidly if their genetic material is not sufficiently tagged with methyl groups, as scientists from the German Cancer Research Center have discovered. Such tags in the DNA appear to act as a shield against cancer-promoting influences.

Tumors grow more rapidly if their genetic material is not sufficiently tagged with methyl groups, as scientists from the German Cancer Research Center have discovered. Such tags in the DNA appear to act as a shield against cancer-promoting influences.2013-01-03T00:00:00+01:002013-01-03T00:00:00+01:00http://www.kit.edu/visit/12436_12441.phpHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Shopping is more than the rational exchange of goods against money. Emotions, however, do not only play a role when buying a red sports car or the fiftieth pair of shoes. At the stock exchange or during auctions, bidders also are often influenced by irrational motives. In the current issue of the International Journal of Electronic Commerce, KIT scientists point out that the end price of auctions depends on the framework conditions and the emotional pressure of the bidders.

Shopping is more than the rational exchange of goods against money. Emotions, however, do not only play a role when buying a red sports car or the fiftieth pair of shoes. At the stock exchange or during auctions, bidders also are often influenced by irrational motives. In the current issue of the International Journal of Electronic Commerce, KIT scientists point out that the end price of auctions depends on the framework conditions and the emotional pressure of the bidders.2012-12-27T01:00:00+01:002012-12-27T01:00:00+01:00http://www.mdc-berlin.de/en/news/2012/20121227-mdc_celebrates_its_20th_anniversary_and_pl/index.htmlHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

In a ceremony under the motto “Research and Responsibility” the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch celebrated its 20th anniversary on Friday, December 7, 2012. Germany’s Education and Research Minister Annette Schavan gave the keynote address in the Max Delbrück Communications Center (MDC.C). Also present at the event were Cornelia Yzer, the Berlin Senator for Economics, Technology and Research, Professor Jürgen Mlynek, President of the Helmholtz Association of which the MDC is a member, and numerous representatives from politics and science.

In a ceremony under the motto “Research and Responsibility” the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch celebrated its 20th anniversary on Friday, December 7, 2012. Germany’s Education and Research Minister Annette Schavan gave the keynote address in the Max Delbrück Communications Center (MDC.C). Also present at the event were Cornelia Yzer, the Berlin Senator for Economics, Technology and Research, Professor Jürgen Mlynek, President of the Helmholtz Association of which the MDC is a member, and numerous representatives from politics and science.2012-12-27T01:00:00+01:002012-12-27T01:00:00+01:00http://www.mdc-berlin.de/en/news/archive/2012/20121227-mdc_celebrates_its_20th_anniversary_and_pl/index.htmlHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

In a ceremony under the motto “Research and Responsibility” the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch celebrated its 20th anniversary on Friday, December 7, 2012. Germany’s Education and Research Minister Annette Schavan gave the keynote address in the Max Delbrück Communications Center (MDC.C). Also present at the event were Cornelia Yzer, the Berlin Senator for Economics, Technology and Research, Professor Jürgen Mlynek, President of the Helmholtz Association of which the MDC is a member, and numerous representatives from politics and science.

In a ceremony under the motto “Research and Responsibility” the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch celebrated its 20th anniversary on Friday, December 7, 2012. Germany’s Education and Research Minister Annette Schavan gave the keynote address in the Max Delbrück Communications Center (MDC.C). Also present at the event were Cornelia Yzer, the Berlin Senator for Economics, Technology and Research, Professor Jürgen Mlynek, President of the Helmholtz Association of which the MDC is a member, and numerous representatives from politics and science.2012-12-21T10:00:00+01:002012-12-21T10:00:00+01:00http://www.helmholtz-berlin.de/pubbin/news_seite?nid=13643;sprache=en;typoid=3228Helmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Dr. Andrei Varykhalov and his colleagues in the group of Prof. Dr. Oliver Rader investigated at BESSY II the electronic properties of nickel coated with graphene and achieved an astonishing result. They could show that the conduction electrons of the graphene behave rather as light than as particles. Physicists had originally expected such behavior only for freestanding graphene layers which show a perfect honeycomb structure and not for graphene on nickel which disturbs the perfect hexagonal symmetry. Their results are supported by calculations of two theoretical groups using novel concepts. Their report was published yesterday evening in the open access journal, Phys. Rev. X, the new top...

Dr. Andrei Varykhalov and his colleagues in the group of Prof. Dr. Oliver Rader investigated at BESSY II the electronic properties of nickel coated with graphene and achieved an astonishing result. They could show that the conduction electrons of the graphene behave rather as light than as particles. Physicists had originally expected such behavior only for freestanding graphene layers which show a perfect honeycomb structure and not for graphene on nickel which disturbs the perfect hexagonal symmetry. Their results are supported by calculations of two theoretical groups using novel concepts. Their report was published yesterday evening in the open access journal, Phys. Rev. X, the new top...2012-12-20T08:00:00+01:002012-12-20T08:00:00+01:00http://www.dlr.de/dlr/presse/en/desktopdefault.aspx/tabid-10172/213_read-5925/Helmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Reliably monitoring extensive areas of the sea is a major challenge for the coastguard and emergency relief services. Unmanned aircraft are expected to make a critical contribution to this in the future.

Reliably monitoring extensive areas of the sea is a major challenge for the coastguard and emergency relief services. Unmanned aircraft are expected to make a critical contribution to this in the future.2012-12-20T00:00:00+01:002012-12-20T00:00:00+01:00http://www.hzdr.de/db/Cms?pNid=99&pOid=38346Helmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Am HZDR wird zum 1. Januar 2013 ein neues Institut für Radioonkologie gegründet. Institutsdirektor ist der Dresdner Krebsforscher Prof. Michael Baumann, der auch die Klinik für Strahlentherapie und Radioonkologie am Universitätsklinikum Dresden leitet sowie für das Dresdner OncoRay-Zentrum spricht.

Am HZDR wird zum 1. Januar 2013 ein neues Institut für Radioonkologie gegründet. Institutsdirektor ist der Dresdner Krebsforscher Prof. Michael Baumann, der auch die Klinik für Strahlentherapie und Radioonkologie am Universitätsklinikum Dresden leitet sowie für das Dresdner OncoRay-Zentrum spricht.2012-12-20T00:00:00+01:002012-12-20T00:00:00+01:00http://www.hzdr.de/db/Cms?pNid=99&pOid=38346Helmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Am HZDR wird zum 1. Januar 2013 ein neues Institut für Radioonkologie gegründet. Institutsdirektor ist der Dresdner Krebsforscher Prof. Michael Baumann, der auch die Klinik für Strahlentherapie und Radioonkologie am Universitätsklinikum Dresden leitet sowie für das Dresdner OncoRay-Zentrum spricht.

Am HZDR wird zum 1. Januar 2013 ein neues Institut für Radioonkologie gegründet. Institutsdirektor ist der Dresdner Krebsforscher Prof. Michael Baumann, der auch die Klinik für Strahlentherapie und Radioonkologie am Universitätsklinikum Dresden leitet sowie für das Dresdner OncoRay-Zentrum spricht.2012-12-19T12:26:05+01:002012-12-19T12:26:05+01:00http://www.awi.de/en/news/press_releases/detail/item/death_in_the_egg/?cHash=6e98259ab49edba336bb03a9efc25426Helmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Up to now the shore crab has belonged to those animal species thought by scientists to be more or less immune to climate change. One reason for this was that the crabs are highly tolerant to extremes temperature and feel just as at home in the eight degrees offered by the Atlantic as they do in the 20 degrees warm Mediterranean. A study conducted by German and Italian scientists has now shown, however, that shore crabs react most sensitively to temperature anomalies at certain times of life – as embryos in the egg.

Up to now the shore crab has belonged to those animal species thought by scientists to be more or less immune to climate change. One reason for this was that the crabs are highly tolerant to extremes temperature and feel just as at home in the eight degrees offered by the Atlantic as they do in the 20 degrees warm Mediterranean. A study conducted by German and Italian scientists has now shown, however, that shore crabs react most sensitively to temperature anomalies at certain times of life – as embryos in the egg.2012-12-19T10:00:00+01:002012-12-19T10:00:00+01:00http://www.fz-juelich.de/SharedDocs/Pressemitteilungen/UK/EN/2012/12-12-19geoverbund.htmlHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Aachen, Bonn, Jülich, Cologne, 19 December 2012 – Geoscience students at RWTH Aachen University and the universities of Bonn and Cologne can now take part in lectures and seminars at all three sites free of charge if they are enrolled at one of the universities. This only used to be possible if students were prepared to pay a three-figure sum per semester to register at a second university. The offices of the three rectors have now signed an agreement implementing this innovation. This measure was initiated by the Geoverbund ABC/J, a network comprising Forschungszentrum Jülich, RWTH Aachen University, and the universities of Bonn and Cologne, focusing on the human-earth system in the context of global change.

Aachen, Bonn, Jülich, Cologne, 19 December 2012 – Geoscience students at RWTH Aachen University and the universities of Bonn and Cologne can now take part in lectures and seminars at all three sites free of charge if they are enrolled at one of the universities. This only used to be possible if students were prepared to pay a three-figure sum per semester to register at a second university. The offices of the three rectors have now signed an agreement implementing this innovation. This measure was initiated by the Geoverbund ABC/J, a network comprising Forschungszentrum Jülich, RWTH Aachen University, and the universities of Bonn and Cologne, focusing on the human-earth system in the context of global change.2012-12-17T11:27:00+01:002012-12-17T11:27:00+01:00http://www.dkfz.de/en/presse/pressemitteilungen/2012/dkfz-pm-12-66-Preventive-Detention-for-Oxidizing-Agents.phpHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Oxidative stress is believed to cause a number of diseases. Up to now, it has been common practice to measure oxidative stress levels by determining the oxidation state of a small molecule called glutathione in cell extracts. Scientists from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) have been the first to discover that cells under stress deposit their oxidized glutathione in a cellular waste repository. This protects cells from oxidative stress – and questions the validity of the conventional measuring method.

Oxidative stress is believed to cause a number of diseases. Up to now, it has been common practice to measure oxidative stress levels by determining the oxidation state of a small molecule called glutathione in cell extracts. Scientists from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) have been the first to discover that cells under stress deposit their oxidized glutathione in a cellular waste repository. This protects cells from oxidative stress – and questions the validity of the conventional measuring method.2012-12-14T09:00:00+01:002012-12-14T09:00:00+01:00http://www.helmholtz-hzi.de/en/news_events/news/view/article/complete/human_against_virus_a_molecular_race/Helmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Immunologists discover a novel target to suppress a common virus. Most people become infected with the human cytomegalovirus (CMV) at some point in life. Over millions of years, our immune system has evolved a trick or two to defend us against this virus, but unfortunately, CMV evolved its own tricks, too. New drugs to target viral genes that counter the immune response might support the immune system in the fight against this widespread virus. The idea ...

Immunologists discover a novel target to suppress a common virus. Most people become infected with the human cytomegalovirus (CMV) at some point in life. Over millions of years, our immune system has evolved a trick or two to defend us against this virus, but unfortunately, CMV evolved its own tricks, too. New drugs to target viral genes that counter the immune response might support the immune system in the fight against this widespread virus. The idea ...2012-12-13T14:59:01+01:002012-12-13T14:59:01+01:00http://www.fz-juelich.de/SharedDocs/Pressemitteilungen/UK/EN/2012/12-12-14erc-grant.htmlHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Physicist Rafal Dunin-Borkowski, Professor at Forschungszentrum Jülich and RWTH Aachen University has been awarded a prestigious Advanced Grant from the European Research Council (ERC). The Director at the Ernst Ruska-Centre for Microscopy and Spectroscopy with Electrons will use the funding, worth € 2.5 million over a period of five years, for the development of electron microscopy methods which allow the mapping of magnetic fields in the interior of materials at almost atomic resolution. Fundamental research in the field of nanomagnetism stands to benefit from the success of this project as well as application-oriented research.

Physicist Rafal Dunin-Borkowski, Professor at Forschungszentrum Jülich and RWTH Aachen University has been awarded a prestigious Advanced Grant from the European Research Council (ERC). The Director at the Ernst Ruska-Centre for Microscopy and Spectroscopy with Electrons will use the funding, worth € 2.5 million over a period of five years, for the development of electron microscopy methods which allow the mapping of magnetic fields in the interior of materials at almost atomic resolution. Fundamental research in the field of nanomagnetism stands to benefit from the success of this project as well as application-oriented research.2012-12-13T00:00:00+01:002012-12-13T00:00:00+01:00http://www.desy.de/news/@@news-view?id=4221&lang=engHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Gianluca Geloni, Vitali Kocharyan, and Evgeni Saldin will be awarded the Innovation Award on Synchrotron Radiation by the Association of Friends of Helmholtz-Zentrum Berlin. Together with Paul Emma from Lawrence Berkeley National Laboratory, the physicists from DESY and European XFEL will receive the prize for their invention of a self-seeding option that significantly improves X-ray free-electron lasers.

Gianluca Geloni, Vitali Kocharyan, and Evgeni Saldin will be awarded the Innovation Award on Synchrotron Radiation by the Association of Friends of Helmholtz-Zentrum Berlin. Together with Paul Emma from Lawrence Berkeley National Laboratory, the physicists from DESY and European XFEL will receive the prize for their invention of a self-seeding option that significantly improves X-ray free-electron lasers.2012-12-12T11:30:39+01:002012-12-12T11:30:39+01:00http://www.fz-juelich.de/SharedDocs/Pressemitteilungen/UK/EN/2012/12-12-11minerva.htmlHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Jülich, 12 December 2012 – Prof. Joachim Treusch has been awarded the 2012 Minerva Prize by Jülich’s Museum Association. Treusch, who served as Chairman of the Board of Directors of Forschungszentrum Jülich for many years, received the award at an evening ceremony in the Schlosskapelle of the Jülich Citadel on 11 December. Prof. Achim Bachem, chairman of the association, paid tribute to his predecessor in the welcoming address, saying, “We are awarding the Minerva Prize to Joachim Treusch in this anniversary year for his outstanding work in bringing together culture and science in the town of Jülich.”

Jülich, 12 December 2012 – Prof. Joachim Treusch has been awarded the 2012 Minerva Prize by Jülich’s Museum Association. Treusch, who served as Chairman of the Board of Directors of Forschungszentrum Jülich for many years, received the award at an evening ceremony in the Schlosskapelle of the Jülich Citadel on 11 December. Prof. Achim Bachem, chairman of the association, paid tribute to his predecessor in the welcoming address, saying, “We are awarding the Minerva Prize to Joachim Treusch in this anniversary year for his outstanding work in bringing together culture and science in the town of Jülich.”2012-12-11T14:40:00+01:002012-12-11T14:40:00+01:00http://www.dlr.de/dlr/presse/en/desktopdefault.aspx/tabid-10172/213_read-5898/Helmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

The vision is enticing – board in Europe, sit back, and disembark 90 minutes later on the other side of the world, in Australia. But before the SpaceLiner, which is being developed by the Institute of Space Systems at DLR, can fly a route like this for the first time, new technologies still have to be tested and basic requirements defined.

The vision is enticing – board in Europe, sit back, and disembark 90 minutes later on the other side of the world, in Australia. But before the SpaceLiner, which is being developed by the Institute of Space Systems at DLR, can fly a route like this for the first time, new technologies still have to be tested and basic requirements defined.2012-12-11T01:00:00+01:002012-12-11T01:00:00+01:00http://www.mdc-berlin.de/en/news/2012/20121211-professor_michael_glickman_of_technion_to_/index.htmlHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

The chemist Professor Michael Glickman of Technion, the Israel Institute of Technology in Haifa, has been named to receive the Friedrich Wilhelm Bessel Research Award of the Alexander von Humboldt Foundation (AvH) for his outstanding research achievements. With the award, which is endowed with 45,000 euros, Professor Glickman will intensify his long-standing collaboration with the cell biologist Professor Thomas Sommer at the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch, and he will also conduct research at the MDC. The award will be presented to him in the spring of next year.

The chemist Professor Michael Glickman of Technion, the Israel Institute of Technology in Haifa, has been named to receive the Friedrich Wilhelm Bessel Research Award of the Alexander von Humboldt Foundation (AvH) for his outstanding research achievements. With the award, which is endowed with 45,000 euros, Professor Glickman will intensify his long-standing collaboration with the cell biologist Professor Thomas Sommer at the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch, and he will also conduct research at the MDC. The award will be presented to him in the spring of next year.2012-12-11T01:00:00+01:002012-12-11T01:00:00+01:00http://www.mdc-berlin.de/en/news/archive/2012/20121211-professor_michael_glickman_of_technion_to_/index.htmlHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

The chemist Professor Michael Glickman of Technion, the Israel Institute of Technology in Haifa, has been named to receive the Friedrich Wilhelm Bessel Research Award of the Alexander von Humboldt Foundation (AvH) for his outstanding research achievements. With the award, which is endowed with 45,000 euros, Professor Glickman will intensify his long-standing collaboration with the cell biologist Professor Thomas Sommer at the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch, and he will also conduct research at the MDC. The award will be presented to him in the spring of next year.

The chemist Professor Michael Glickman of Technion, the Israel Institute of Technology in Haifa, has been named to receive the Friedrich Wilhelm Bessel Research Award of the Alexander von Humboldt Foundation (AvH) for his outstanding research achievements. With the award, which is endowed with 45,000 euros, Professor Glickman will intensify his long-standing collaboration with the cell biologist Professor Thomas Sommer at the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch, and he will also conduct research at the MDC. The award will be presented to him in the spring of next year.2012-12-11T00:00:00+01:002012-12-11T00:00:00+01:00http://www.helmholtz-hzi.de/en/news_events/news/view/article/complete/new_insights_on_phagosome_maturation/Helmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Phagocytes ingest particles as well as pathogens from their surroundings into compartments called phagosomes. The phagosomes possess a harsh milieu with microbicidal function; therefore the phagocytes represent the first line of defense against infections. However, some intracellular pathogens, including members of mycobacterial species, manipulate the phagosomes to survive within them.

Phagocytes ingest particles as well as pathogens from their surroundings into compartments called phagosomes. The phagosomes possess a harsh milieu with microbicidal function; therefore the phagocytes represent the first line of defense against infections. However, some intracellular pathogens, including members of mycobacterial species, manipulate the phagosomes to survive within them.2012-12-10T15:31:36+01:002012-12-10T15:31:36+01:00http://www.fz-juelich.de/SharedDocs/Pressemitteilungen/UK/EN/2012/12-12-10azubis.htmlHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Jülich, 10 December 2012 – Vanessa Derichs, Carsten Graf, Ingo Heimbach and Florian Rhiem are among the best trainees in Germany. The materials tester, the industrial electrician and the two mathematical and technical software developers from Forschungszentrum Jülich passed their final examinations with the best marks nationwide in their chosen occupations. At a ceremony hosted by the Federal Chamber of Industry and Commerce in Berlin today, together with the other top-ranking trainees, they will be presented with a special award by the Federal Minister for Family Affairs, Kristina Schröder.

Jülich, 10 December 2012 – Vanessa Derichs, Carsten Graf, Ingo Heimbach and Florian Rhiem are among the best trainees in Germany. The materials tester, the industrial electrician and the two mathematical and technical software developers from Forschungszentrum Jülich passed their final examinations with the best marks nationwide in their chosen occupations. At a ceremony hosted by the Federal Chamber of Industry and Commerce in Berlin today, together with the other top-ranking trainees, they will be presented with a special award by the Federal Minister for Family Affairs, Kristina Schröder.2012-12-10T10:00:00+01:002012-12-10T10:00:00+01:00http://www.helmholtz-hzi.de/en/news_events/news/view/article/complete/working_together_against_alzheimers_parkinsons_and_dementia/Helmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Collaboration between two Helmholtz Centres: Neuroscientists and infection researchers focus on interdisciplinary partnership to study brain diseases. & Two institutions of the Helmholtz Association are joining forces for health research: How does the brain protect itself from pathogens? Can infections favour Alzheimer's disease? Scientists from the German Center for Neurodegenerative Diseases (DZNE) in Bonn and the Helmholtz Centre for Infection Research (HZI) in Braunschweig want to tackle such questions together over the next few ...

Collaboration between two Helmholtz Centres: Neuroscientists and infection researchers focus on interdisciplinary partnership to study brain diseases. & Two institutions of the Helmholtz Association are joining forces for health research: How does the brain protect itself from pathogens? Can infections favour Alzheimer's disease? Scientists from the German Center for Neurodegenerative Diseases (DZNE) in Bonn and the Helmholtz Centre for Infection Research (HZI) in Braunschweig want to tackle such questions together over the next few ...2012-12-10T00:00:00+01:002012-12-10T00:00:00+01:00http://www.dzne.de/en/about-us/public-relations/meldungen/2012/press-release-no-30.htmlHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Two institutions of the Helmholtz Association are joining forces for health research: How does the brain protect itself from pathogens? Can infections favour Alzheimer’s disease? Scientists from the German Center for Neurodegenerative Diseases (DZNE) in Bonn and the Helmholtz Centre for Infection Research (HZI) in Braunschweig want to tackle such questions together over the next few years. The interdisciplinary collaboration will receive funding of approximately 600,000 Euro. The researchers hope to discover new facts about dementia and other brain diseases.

Two institutions of the Helmholtz Association are joining forces for health research: How does the brain protect itself from pathogens? Can infections favour Alzheimer’s disease? Scientists from the German Center for Neurodegenerative Diseases (DZNE) in Bonn and the Helmholtz Centre for Infection Research (HZI) in Braunschweig want to tackle such questions together over the next few years. The interdisciplinary collaboration will receive funding of approximately 600,000 Euro. The researchers hope to discover new facts about dementia and other brain diseases.2012-12-07T11:10:00+01:002012-12-07T11:10:00+01:00http://www.dlr.de/dlr/presse/en/desktopdefault.aspx/tabid-10172/213_read-5861/Helmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Many disciplines are involved in the design and development of an aircraft. To obtain the best combination of wings, fuselage and engines, researchers must work closely together and share their expertise effectively.

Many disciplines are involved in the design and development of an aircraft. To obtain the best combination of wings, fuselage and engines, researchers must work closely together and share their expertise effectively.2012-12-06T10:00:00+01:002012-12-06T10:00:00+01:00http://www.dkfz.de/en/presse/pressemitteilungen/2012/dkfz-pm-12-65-Cocktail-Boosts-Immune-Cells-in-Fighting-Cancer.phpHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Natural killer cells (or NK cells), as part of the body´s immune system, can effectively fight cancer. Unfortunately, they quickly lose their aggressiveness and hence are unable to reject solid tumors. Scientists from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) have now discovered a cocktail consisting of three different immune mediators that leaves NK killer cells active over a long period of time. In mice, cocktail-boosted NK cells let tumors shrink. The cocktail was able to persistently activate human NK cells, too.

Natural killer cells (or NK cells), as part of the body´s immune system, can effectively fight cancer. Unfortunately, they quickly lose their aggressiveness and hence are unable to reject solid tumors. Scientists from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) have now discovered a cocktail consisting of three different immune mediators that leaves NK killer cells active over a long period of time. In mice, cocktail-boosted NK cells let tumors shrink. The cocktail was able to persistently activate human NK cells, too.2012-12-06T09:50:49+01:002012-12-06T09:50:49+01:00http://www.fz-juelich.de/SharedDocs/Pressemitteilungen/UK/EN/2012/12-12-06Elektronenkuehler.htmlHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

A new electron cooler for the Jülich particle accelerator COSY has arrived at Forschungszentrum Jülich after a 12-day journey by heavy truck from Novosibirsk nearly 6000 kilometres away. The two-megavolt cooling system developed in cooperation with the Budker Institute of Nuclear Physics will enable COSY to detect extremely rare high-energy decay processes of significance in the search for exotic forms of matter and effects outside the realms of the standard model of particle physics.

A new electron cooler for the Jülich particle accelerator COSY has arrived at Forschungszentrum Jülich after a 12-day journey by heavy truck from Novosibirsk nearly 6000 kilometres away. The two-megavolt cooling system developed in cooperation with the Budker Institute of Nuclear Physics will enable COSY to detect extremely rare high-energy decay processes of significance in the search for exotic forms of matter and effects outside the realms of the standard model of particle physics.2012-12-05T15:12:00+01:002012-12-05T15:12:00+01:00http://www.dkfz.de/en/presse/pressemitteilungen/2012/dkfz-pm-12-64-Tobacco-Prevention-in-Germany-A-Success-Story-with-Many-Challenges-Still-Ahead.phpHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Smoking is “out”, non-smoking is “in” – particularly among youth: The number of young people trying cigarettes or becoming regular smokers is declining. In the past decade, the smoker´s rate among youth has dropped from 28 percent to less than 12 percent. The German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) has brought forward this success in health protection. The WHO Collaborating Centre for Tobacco Control, based at DKFZ, has contributed effective measures for reducing tobacco use to the public debate. In collaboration with other national and international partners it supports decision-makers in implementing such measures.

Smoking is “out”, non-smoking is “in” – particularly among youth: The number of young people trying cigarettes or becoming regular smokers is declining. In the past decade, the smoker´s rate among youth has dropped from 28 percent to less than 12 percent. The German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) has brought forward this success in health protection. The WHO Collaborating Centre for Tobacco Control, based at DKFZ, has contributed effective measures for reducing tobacco use to the public debate. In collaboration with other national and international partners it supports decision-makers in implementing such measures.2012-12-04T11:51:00+01:002012-12-04T11:51:00+01:00http://www.dkfz.de/en/presse/pressemitteilungen/2012/dkfz-pm-12-63-International-Research-Award-for-Ingrid-Grummt.phpHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

The French National Institute of Health and Medical Research (Inserm) awards its prestigious “Prix International” to Ingrid Grummt this year. The scientist from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) is honored for her life’s work. Grummt studies the role of RNA molecules regulating gene expression.

The French National Institute of Health and Medical Research (Inserm) awards its prestigious “Prix International” to Ingrid Grummt this year. The scientist from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) is honored for her life’s work. Grummt studies the role of RNA molecules regulating gene expression.2012-12-04T10:37:45+01:002012-12-04T10:37:45+01:00http://www.awi.de/en/news/press_releases/detail/item/how_cold_will_winter_be_in_two_years/?cHash=89449127b8b7525e6c34f4fd9a293237Helmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

How well are the most important climate models able to predict the weather conditions for the coming year or even the next decade? The Potsdam scientists Dr. Dörthe Handorf and Prof. Dr. Klaus Dethloff from the Alfred Wegener Institute for Polar and Marine Research in the Helmholtz Association (AWI) have evaluated 23 climate models and published their results in the current issue of the international scientific journal Tellus A.

How well are the most important climate models able to predict the weather conditions for the coming year or even the next decade? The Potsdam scientists Dr. Dörthe Handorf and Prof. Dr. Klaus Dethloff from the Alfred Wegener Institute for Polar and Marine Research in the Helmholtz Association (AWI) have evaluated 23 climate models and published their results in the current issue of the international scientific journal Tellus A.2012-12-03T15:44:00+01:002012-12-03T15:44:00+01:00http://www.fz-juelich.de/SharedDocs/Pressemitteilungen/UK/EN/2012/12-012-03solliance.htmlHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Forschungszentrum Jülich and Solliance announce a new partnership in the field of thin film photovoltaics. Solliance is a cross-border initiative by ECN, imec, Holst Centre, TNO and TU Eindhoven. With Jülich as an additional partner, Solliance grows further as R&D cluster bringing thin film solar energy technology to excellence and is ramping up its activities to gain market share internationally. Some partner companies are successful global players in their segment already. The science and technology in this field are world class in selected areas, with a track record of 15 to 30 years.

Forschungszentrum Jülich and Solliance announce a new partnership in the field of thin film photovoltaics. Solliance is a cross-border initiative by ECN, imec, Holst Centre, TNO and TU Eindhoven. With Jülich as an additional partner, Solliance grows further as R&D cluster bringing thin film solar energy technology to excellence and is ramping up its activities to gain market share internationally. Some partner companies are successful global players in their segment already. The science and technology in this field are world class in selected areas, with a track record of 15 to 30 years.2012-12-03T14:38:00+01:002012-12-03T14:38:00+01:00http://www.dkfz.de/en/presse/pressemitteilungen/2012/dkfz-pm-12-62-Scientists-Discover-Molecular-Switch-Involved-in-Lymphoma.phpHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Scientists from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) have discovered a molecular switch that plays a role in the development of lymphoma: If a protein called PP4R1 is missing, T cells can divide in an uncontrolled manner, migrate through the body and eventually form skin tumors. The researchers have published their results in the specialist journal “Immunity”.

Scientists from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) have discovered a molecular switch that plays a role in the development of lymphoma: If a protein called PP4R1 is missing, T cells can divide in an uncontrolled manner, migrate through the body and eventually form skin tumors. The researchers have published their results in the specialist journal “Immunity”.2012-12-03T00:00:00+01:002012-12-03T00:00:00+01:00http://www.dzne.de/en/about-us/public-relations/meldungen/2012/press-release-no-28.htmlHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Scientists from the German Center for Neurodegenerative Diseases (DZNE) are participating in an international research project on the causes of rare degenerative brain and muscle disorders. Over the next five years, the DNZE Bonn site will receive 470,000 euros for the effort. The project, entitled "NEUROMICS: Integrated European Project on Omics Research of Rare Neuromuscular and Neurodegenerative Diseases," is being funded under the EU's Seventh Framework Programme for Research. The partners in the effort hail from Europe, Australia, Canada and the United States. "Such a concerted effort on this scale is unprecedented," explains Prof. Thomas Klockgether, Director of Clinical Research at the DZNE. Relevant work in Bonn will focus on patients and healthy people with increased risks of disease. "We expect the work to yield new findings on the causes of such diseases and to provide impetus for diagnosis and therapy," notes Klockgether.

Scientists from the German Center for Neurodegenerative Diseases (DZNE) are participating in an international research project on the causes of rare degenerative brain and muscle disorders. Over the next five years, the DNZE Bonn site will receive 470,000 euros for the effort. The project, entitled "NEUROMICS: Integrated European Project on Omics Research of Rare Neuromuscular and Neurodegenerative Diseases," is being funded under the EU's Seventh Framework Programme for Research. The partners in the effort hail from Europe, Australia, Canada and the United States. "Such a concerted effort on this scale is unprecedented," explains Prof. Thomas Klockgether, Director of Clinical Research at the DZNE. Relevant work in Bonn will focus on patients and healthy people with increased risks of disease. "We expect the work to yield new findings on the causes of such diseases and to provide impetus for diagnosis and therapy," notes Klockgether.2012-12-01T00:00:00+01:002012-12-01T00:00:00+01:00http://www.desy.de/information__services/press/pressreleases/@@news-view?id=4201&lang=engHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

With the X-ray vision of DESY's light source DORIS, a research team from Hamburg and Iceland has uncovered the molecular structure of a master regulator central to the most deadly form of skin cancer, melanoma. The results, published in the scientific journal "Genes & Development", throw new light on the workings of the so-called Microphthalmia-associated Transcription Factor MITF, that is not only connected to skin cancer, but also to a variety of hereditary diseases where the production of the skin pigment melanin is disturbed, and to certain aspects of ageing. "Our data could provide a rational basis for the development of tailor-made drugs targeting MITF", explains first author Vivian Pogenberg from the Hamburg branch of the European Molecular Biology Laboratory (EMBL).

With the X-ray vision of DESY's light source DORIS, a research team from Hamburg and Iceland has uncovered the molecular structure of a master regulator central to the most deadly form of skin cancer, melanoma. The results, published in the scientific journal "Genes & Development", throw new light on the workings of the so-called Microphthalmia-associated Transcription Factor MITF, that is not only connected to skin cancer, but also to a variety of hereditary diseases where the production of the skin pigment melanin is disturbed, and to certain aspects of ageing. "Our data could provide a rational basis for the development of tailor-made drugs targeting MITF", explains first author Vivian Pogenberg from the Hamburg branch of the European Molecular Biology Laboratory (EMBL).2012-11-30T11:58:00+01:002012-11-30T11:58:00+01:00http://www.helmholtz-hzi.de/en/news_events/news/view/article/complete/concentrated_competencies_in_the_fight_against_infectious_diseases/Helmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

HZI and the Robert Koch Institute sign collaboration agreement. Press date: December 6, 3:15 pm. Two leaders in the field of infection research are planning on bundling their expertise in the future. Scientists at the Helmholtz Centre for Infection Research (HZI) in Braunschweig and at the Robert Koch Institute (RKI) in Berlin and Wernigerode will be sharing their resources and potentials to find answers to pressing questions of infection research and epidemiology. The two research institutes' ...

HZI and the Robert Koch Institute sign collaboration agreement. Press date: December 6, 3:15 pm. Two leaders in the field of infection research are planning on bundling their expertise in the future. Scientists at the Helmholtz Centre for Infection Research (HZI) in Braunschweig and at the Robert Koch Institute (RKI) in Berlin and Wernigerode will be sharing their resources and potentials to find answers to pressing questions of infection research and epidemiology. The two research institutes' ...2012-11-30T11:40:00+01:002012-11-30T11:40:00+01:00http://www.dkfz.de/en/presse/pressemitteilungen/2012/dkfz-pm-12-61-Thomas-Hofmann-Wins-the-Prize-of-the-Berlin-Brandenburg-Academy-of-Sciences-and-Humanities.phpHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Dr. Thomas Hofmann, junior research group leader at the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ), is awarded the €10,000 prize for his outstanding achievements in cancer research. Hofmann, a biologist, unraveled the mechanisms by which cells decide upon their further fate following DNA damage. His findings help to understand how cancer cells respond to therapies involving DNA damage.

Dr. Thomas Hofmann, junior research group leader at the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ), is awarded the €10,000 prize for his outstanding achievements in cancer research. Hofmann, a biologist, unraveled the mechanisms by which cells decide upon their further fate following DNA damage. His findings help to understand how cancer cells respond to therapies involving DNA damage.2012-11-30T00:00:00+01:002012-11-30T00:00:00+01:00http://www.dzne.de/en/about-us/public-relations/meldungen/2012/press-release-no-27.htmlHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Researchers at the German Center for Neurodegenerative Diseases (DZNE) and the University Medical Center Göttingen (UMG) have identified an enzyme as a possible target for the treatment of Alzheimer’s disease. The protein known as HDAC6 impairs transport processes within the nerve cells. The scientists observed only mild symptoms of the disease in mice if the enzyme was not produced. They propose to block its activity in a targeted fashion to treat the disease. Scientists from the DZNE sites in Göttingen and Bonn, the UMG as well as from the US participated in this basic research project on Alzheimer’s disease. The study is published in "EMBO Molecular Medicine".

Researchers at the German Center for Neurodegenerative Diseases (DZNE) and the University Medical Center Göttingen (UMG) have identified an enzyme as a possible target for the treatment of Alzheimer’s disease. The protein known as HDAC6 impairs transport processes within the nerve cells. The scientists observed only mild symptoms of the disease in mice if the enzyme was not produced. They propose to block its activity in a targeted fashion to treat the disease. Scientists from the DZNE sites in Göttingen and Bonn, the UMG as well as from the US participated in this basic research project on Alzheimer’s disease. The study is published in "EMBO Molecular Medicine".2012-11-29T18:00:00+01:002012-11-29T18:00:00+01:00http://www.helmholtz-hzi.de/en/news_events/news/view/article/complete/traffic_cops_of_the_immune_system/Helmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Molecule called IκBNS in charge of regulatory immune cell maturation. A certain type of immune cell – the regulatory T cell, or Treg for short – is in charge of putting on the brakes on the immune response. In a way, this cell type might be considered the immune system"s traffic cop. Now, scientists at the Helmholtz Centre for Infection Research (HZI) have looked into the origin of Tregs and uncovered a central role played by the protein IκBNS.

Molecule called IκBNS in charge of regulatory immune cell maturation. A certain type of immune cell – the regulatory T cell, or Treg for short – is in charge of putting on the brakes on the immune response. In a way, this cell type might be considered the immune system"s traffic cop. Now, scientists at the Helmholtz Centre for Infection Research (HZI) have looked into the origin of Tregs and uncovered a central role played by the protein IκBNS.2012-11-29T16:00:00+01:002012-11-29T16:00:00+01:00http://www.helmholtz-hzi.de/en/news_events/news/view/article/complete/hzi_part_of_compact/Helmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Public-private partnership for research of new pharmceutics. The Helmholtz Centre for Infection Research (HZI) and its branch Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) are partners in & the project& COMPACT (Collaboration on the Optimisation of Macromolecular Pharmaceutical Access to Cellular Targets), initiated by the pharma company Sanofi. Thirteen further& academic research facilities, six pharmaceutical companies ...

Public-private partnership for research of new pharmceutics. The Helmholtz Centre for Infection Research (HZI) and its branch Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) are partners in & the project& COMPACT (Collaboration on the Optimisation of Macromolecular Pharmaceutical Access to Cellular Targets), initiated by the pharma company Sanofi. Thirteen further& academic research facilities, six pharmaceutical companies ...2012-11-29T13:44:05+01:002012-11-29T13:44:05+01:00http://www.awi.de/en/news/press_releases/detail/item/new_approach_allows_past_data_to_be_used_to_improve_future_climate_projections/?cHash=63fb25d9eaada95414ce6ab335ca2a13Helmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Climate scientists are still grappling with one of the main questions of modern times: how high will global temperatures rise if the atmospheric concentration of carbon dioxide doubles. Many researchers are now turning to the past because it holds clues to how nature reacted to climate change before the anthropogenic impact. The divergent results of this research, however, have made it difficult to make precise predictions about the impact of increased carbon dioxide on future warming. An international team of scientists have evaluated previously published estimates and assigned them consistent categories and terminology.

Climate scientists are still grappling with one of the main questions of modern times: how high will global temperatures rise if the atmospheric concentration of carbon dioxide doubles. Many researchers are now turning to the past because it holds clues to how nature reacted to climate change before the anthropogenic impact. The divergent results of this research, however, have made it difficult to make precise predictions about the impact of increased carbon dioxide on future warming. An international team of scientists have evaluated previously published estimates and assigned them consistent categories and terminology.2012-11-29T02:00:00+01:002012-11-29T02:00:00+01:00http://www.gfz-potsdam.de/portal/gfz/Public+Relations/Pressemitteilungen/aktuell/121129_GraceFOHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Astrium, Europe’s leading space technology company, has been commissioned to build two new research satellites for NASA’s Jet Propulsion Laboratory JPL (Pasadena, California). The agreement was signed today in Friedrichshafen, Germany. For a minimum of five years from August 2017, the Gravity Recovery and Climate ExperimentFollow-On (Grace FO) mission will continue the extremely accurate measurement data collection of the first twin Grace satellites, which have been in orbit since 17 March, 2002.

Astrium, Europe’s leading space technology company, has been commissioned to build two new research satellites for NASA’s Jet Propulsion Laboratory JPL (Pasadena, California). The agreement was signed today in Friedrichshafen, Germany. For a minimum of five years from August 2017, the Gravity Recovery and Climate ExperimentFollow-On (Grace FO) mission will continue the extremely accurate measurement data collection of the first twin Grace satellites, which have been in orbit since 17 March, 2002.2012-11-29T00:00:00+01:002012-11-29T00:00:00+01:00http://www.desy.de/information__services/press/pressreleases/@@news-view?id=4161&lang=engHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Using the world's most powerful X-ray laser, scientists have exposed a possible Achilles' heel of the sleeping sickness parasite that threatens more than 60 million people in sub-Saharan Africa. The sophisticated analysis revealed the blueprint for a molecular plug that can selectively block a vital enzyme of the parasite Trypanosoma brucei. Plugging such a tailor-made molecule into the right place of the enzyme would render it inactive, thereby killing the parasite. The team led by DESY scientist Prof. Henry Chapman from the Center of Free-Electron Laser Science (CFEL), Prof. Christian Betzel from the University of Hamburg and Dr. Lars Redecke from the joint Junior Research Group "Structural Infection Biology using new Radiation Sources (SIAS)" of the Universities of Hamburg and Lübeck report their findings in the journal "Science". "This is the first new biological structure solved with a free-electron laser," said Chapman.

Using the world's most powerful X-ray laser, scientists have exposed a possible Achilles' heel of the sleeping sickness parasite that threatens more than 60 million people in sub-Saharan Africa. The sophisticated analysis revealed the blueprint for a molecular plug that can selectively block a vital enzyme of the parasite Trypanosoma brucei. Plugging such a tailor-made molecule into the right place of the enzyme would render it inactive, thereby killing the parasite. The team led by DESY scientist Prof. Henry Chapman from the Center of Free-Electron Laser Science (CFEL), Prof. Christian Betzel from the University of Hamburg and Dr. Lars Redecke from the joint Junior Research Group "Structural Infection Biology using new Radiation Sources (SIAS)" of the Universities of Hamburg and Lübeck report their findings in the journal "Science". "This is the first new biological structure solved with a free-electron laser," said Chapman.2012-11-28T14:00:00+01:002012-11-28T14:00:00+01:00http://www.dlr.de/dlr/presse/en/desktopdefault.aspx/tabid-10172/213_read-5773/Helmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

To the naked eye there is nothing to see, and yet the small transparent container holds something never observed before. For the first time, scientists are studying asteroid dust collected by a spacecraft and returned to Earth. Ute Böttger, from the Institute of Planetary Research at the German Aerospace Center (Deutsches Zentrum für Luft- und Raumfahrt; DLR), belongs to one of 11 teams across the world that are carrying out scientific work on the asteroid particles from the Japanese Hayabusa mission.

To the naked eye there is nothing to see, and yet the small transparent container holds something never observed before. For the first time, scientists are studying asteroid dust collected by a spacecraft and returned to Earth. Ute Böttger, from the Institute of Planetary Research at the German Aerospace Center (Deutsches Zentrum für Luft- und Raumfahrt; DLR), belongs to one of 11 teams across the world that are carrying out scientific work on the asteroid particles from the Japanese Hayabusa mission.2012-11-28T13:29:00+01:002012-11-28T13:29:00+01:00http://www.dkfz.de/en/presse/pressemitteilungen/2012/dkfz-pm-12-58c-How-Aggregated-Proteins-CanReturn-to-Their-Original-Shape.phpHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Anybody knows the process that happens when you cook an egg: The initially liquid and transparent egg white turns solid and opaque. Heidelberg scientists from the Center for Molecular Biology (ZMBH) at Heidelberg University and the German Cancer Research Center (DKFZ) have now discovered and unraveled a repair system used by cells to revert this protein aggregation. Experts from the Heidelberg Institute for Theoretical Studies (HITS) also participated in the research project. The scientists have now reported their research results in two simultaneously published articles in the specialist journal “Nature Structural and Molecular Biology”.

Anybody knows the process that happens when you cook an egg: The initially liquid and transparent egg white turns solid and opaque. Heidelberg scientists from the Center for Molecular Biology (ZMBH) at Heidelberg University and the German Cancer Research Center (DKFZ) have now discovered and unraveled a repair system used by cells to revert this protein aggregation. Experts from the Heidelberg Institute for Theoretical Studies (HITS) also participated in the research project. The scientists have now reported their research results in two simultaneously published articles in the specialist journal “Nature Structural and Molecular Biology”.2012-11-28T11:21:00+01:002012-11-28T11:21:00+01:00http://www.dkfz.de/en/presse/pressemitteilungen/2012/dkfz-pm-12-60-Multiplexion-Assures-Quality-of-Research-Results.phpHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Contamination of cell cultures by bacteria, viruses or other cells is a widespread problem in biomedical research. The company Multiplexion, a spinout from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ), checks cell cultures of clients from research institutes and companies for many different types of contamination and verifies the identity of cell lines. The test is quick and low-cost and contributes to quality assurance and reproducibility of biomedical research results.

Contamination of cell cultures by bacteria, viruses or other cells is a widespread problem in biomedical research. The company Multiplexion, a spinout from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ), checks cell cultures of clients from research institutes and companies for many different types of contamination and verifies the identity of cell lines. The test is quick and low-cost and contributes to quality assurance and reproducibility of biomedical research results.2012-11-27T10:00:00+01:002012-11-27T10:00:00+01:00http://www.helmholtz-berlin.de/pubbin/news_seite?nid=13624;sprache=en;typoid=3228Helmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Ever since graphene was first isolated a few years ago, this quasi-two-dimensional network made up of a single layer of carbon atoms has been considered the magic material. Not only is graphene mechanically highly resilient, it also provides an interesting basis for new spintronic components that exploit the magnetic moment of conduction electrons. Now, Helmholtz Centre Berlins Dr. Andrei Varykhalov, Prof. Dr. Oliver Rader and his team of physicists has taken the first step towards building graphene-based components, in collaboration with physicists from St. Petersburg (Russia), Jülich (Germany) and Harvard (USA). According to their report on 27th November 2012 in Nature Communications (...

Ever since graphene was first isolated a few years ago, this quasi-two-dimensional network made up of a single layer of carbon atoms has been considered the magic material. Not only is graphene mechanically highly resilient, it also provides an interesting basis for new spintronic components that exploit the magnetic moment of conduction electrons. Now, Helmholtz Centre Berlins Dr. Andrei Varykhalov, Prof. Dr. Oliver Rader and his team of physicists has taken the first step towards building graphene-based components, in collaboration with physicists from St. Petersburg (Russia), Jülich (Germany) and Harvard (USA). According to their report on 27th November 2012 in Nature Communications (...2012-11-27T09:13:44+01:002012-11-27T09:13:44+01:00http://www.hzg.de/cms01/public_relations/press_releases/034817/index_0034817.html.enHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

A membrane consisting of polymer fibres and proteins makes a novel filter for tiny, nano-scaled particles in aqueous solutions. The result of such a research, which was done by Professor Mady Elbahri and his team from the Institute of Material Science at the Christian Albrecht University University in Kiel (CAU) and the Institue of Polymer Research at the Helmholtz-Zentrum Geestacht (HZG), has recently been published as the cover article in the current issue (21.11.2012) of "Advanced Functional Materials".

A membrane consisting of polymer fibres and proteins makes a novel filter for tiny, nano-scaled particles in aqueous solutions. The result of such a research, which was done by Professor Mady Elbahri and his team from the Institute of Material Science at the Christian Albrecht University University in Kiel (CAU) and the Institue of Polymer Research at the Helmholtz-Zentrum Geestacht (HZG), has recently been published as the cover article in the current issue (21.11.2012) of "Advanced Functional Materials".2012-11-27T08:41:45+01:002012-11-27T08:41:45+01:00http://www.awi.de/en/news/press_releases/detail/item/first_unep_permafrost_report_relies_on_expertise_of_the_alfred_wegener_institute/?cHash=eeb309d688386dab06527984352396f5Helmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

For the first time the United Nations Environment Programme (UNEP) has today published a Report on the status of the global permafrost regions. In it an international team of experts clearly explains how climate change is impacting the permanently frozen soils in the Arctic, Siberia and in the high mountain regions, which potential hazards emanate from the thawing ground and the far-reaching consequences countries with permafrost must consider. The researchers also call upon politicians and climate scientists to include the knowledge about the change in the permafrost regions to a greater extent in the international climate debate. “The Report shows that in future the change in the permafr

For the first time the United Nations Environment Programme (UNEP) has today published a Report on the status of the global permafrost regions. In it an international team of experts clearly explains how climate change is impacting the permanently frozen soils in the Arctic, Siberia and in the high mountain regions, which potential hazards emanate from the thawing ground and the far-reaching consequences countries with permafrost must consider. The researchers also call upon politicians and climate scientists to include the knowledge about the change in the permafrost regions to a greater extent in the international climate debate. “The Report shows that in future the change in the permafr2012-11-26T16:15:00+01:002012-11-26T16:15:00+01:00http://www.dkfz.de/en/presse/pressemitteilungen/2012/dkfz-pm-12-59-Searching-for-Clues-in-Leukemia-Genomes-Charles-Mullighan-Wins-2012-Meyenburg-Award.phpHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

The 2012 Meyenburg Award of €50,000 goes to physician and researcher Charles G. Mullighan. He is distinguished for his outstanding work in the field of identifying genetic changes leading to the onset of leukemia. Mullighan systematically analyzed tumor genomes of blood cancer cells in order to find new methods for treating children suffering from leukemia. The Meyenburg Award will be presented on Tuesday, November 27, 2012 at a symposium held at the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ).

The 2012 Meyenburg Award of €50,000 goes to physician and researcher Charles G. Mullighan. He is distinguished for his outstanding work in the field of identifying genetic changes leading to the onset of leukemia. Mullighan systematically analyzed tumor genomes of blood cancer cells in order to find new methods for treating children suffering from leukemia. The Meyenburg Award will be presented on Tuesday, November 27, 2012 at a symposium held at the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ).2012-11-26T16:00:00+01:002012-11-26T16:00:00+01:00http://www.dlr.de/dlr/presse/en/desktopdefault.aspx/tabid-10172/213_read-5707/Helmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

There are very few ways of conducting experiments without the influence of Earth's gravity. One of these platforms became available on 25 November 2012, when a rocket was launched from the Swedish Esrange Space Center in Kiruna.

There are very few ways of conducting experiments without the influence of Earth's gravity. One of these platforms became available on 25 November 2012, when a rocket was launched from the Swedish Esrange Space Center in Kiruna.2012-11-26T09:35:00+01:002012-11-26T09:35:00+01:00http://www.fz-juelich.de/SharedDocs/Pressemitteilungen/UK/EN/2012/12-11-22beckurts-stiftung.htmlHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Daimler Research Team Awarded 2012 Beckurts Prize for New Intelligent Driver Assistance System Munich, 26 November 2012 – This year's Karl Heinz Beckurts Prize will be presented on Monday, 26 November, to Dr. Uwe Franke, Dr. Stefan Gehrig and Dr. Clemens Rabe. The three researchers from Daimler AG will receive the prize, endowed with € 30,000, for their "6D Vision", which will in future assist drivers in very complex traffic environments with restricted visibility such as construction sites and intersections. This will make a decisive contribution towards accident reduction.

Daimler Research Team Awarded 2012 Beckurts Prize for New Intelligent Driver Assistance System Munich, 26 November 2012 – This year's Karl Heinz Beckurts Prize will be presented on Monday, 26 November, to Dr. Uwe Franke, Dr. Stefan Gehrig and Dr. Clemens Rabe. The three researchers from Daimler AG will receive the prize, endowed with € 30,000, for their "6D Vision", which will in future assist drivers in very complex traffic environments with restricted visibility such as construction sites and intersections. This will make a decisive contribution towards accident reduction.2012-11-26T00:00:00+01:002012-11-26T00:00:00+01:00http://www.dzne.de/en/about-us/public-relations/meldungen/2012/press-release-no-26.htmlHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

A new substance class for the treatment of multiple sclerosis and other neurodegenerative diseases now promises increased efficacy paired with fewer side effects. To achieve this, a team of scientists under the leadership of Prof. Gunter Fischer (Max Planck Research Unit for Enzymology of Protein Folding, Halle/Saale, Germany) and Dr. Frank Striggow (German Center for Neurodegenerative Diseases (DZNE)) have combined two already approved pharmaceutical substances with each other using a chemical linker structure. The objectives of this combination are to ensure maximum brain cell protection on the one hand and the suppression of unwanted side effects on the other. The new class of substances has now been registered with the European Patent Office as the DZNE’s first patent in the form of a joint patent application with the Max Planck Research Unit. “The patent approval process can take several years. During this phase we are planning to conclude the pre-clinical development. It is our aim to start with clinical research and development at the earliest possible time. Overall, we have identified substantial therapeutic potential as far as chronic and age-related neurodegenerative diseases are concerned,” comments Dr. Frank Striggow.

A new substance class for the treatment of multiple sclerosis and other neurodegenerative diseases now promises increased efficacy paired with fewer side effects. To achieve this, a team of scientists under the leadership of Prof. Gunter Fischer (Max Planck Research Unit for Enzymology of Protein Folding, Halle/Saale, Germany) and Dr. Frank Striggow (German Center for Neurodegenerative Diseases (DZNE)) have combined two already approved pharmaceutical substances with each other using a chemical linker structure. The objectives of this combination are to ensure maximum brain cell protection on the one hand and the suppression of unwanted side effects on the other. The new class of substances has now been registered with the European Patent Office as the DZNE’s first patent in the form of a joint patent application with the Max Planck Research Unit. “The patent approval process can take several years. During this phase we are planning to conclude the pre-clinical development. It is our aim to start with clinical research and development at the earliest possible time. Overall, we have identified substantial therapeutic potential as far as chronic and age-related neurodegenerative diseases are concerned,” comments Dr. Frank Striggow.2012-11-23T01:00:00+01:002012-11-23T01:00:00+01:00http://www.ufz.de/index.php?en=31034Helmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Climate change is affecting all regions in Europe, causing a wide range of impacts on society and the environment. Further impacts are expected in the future, potentially causing high damage costs, according to the latest assessment published by the European Environment Agency today.

Climate change is affecting all regions in Europe, causing a wide range of impacts on society and the environment. Further impacts are expected in the future, potentially causing high damage costs, according to the latest assessment published by the European Environment Agency today.2012-11-23T00:00:00+01:002012-11-23T00:00:00+01:00http://www.dzne.de/en/about-us/public-relations/meldungen/2012/press-release-no-25.htmlHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Prof. Thomas Misgeld from the German Center for Neurodegenerative Diseases (DZNE) as well as the Technischen Universität München and Prof. Boris Schmidt, Technische Universität Darmstadt, have been awarded with the 2012 Hans and Ilse Breuer Foundation Alzheimer Research Award. The prize money totals 100,000 EUR and will be shared between the two scientists. The award ceremony took place on the 21st of November as part of the Eibsee Meeting “Cellular mechanisms of neurodegeneration”. “We congratulate Thomas Misgeld for receiving this prestigious award“, notes Prof. Pierluigi Nicotera, Scientific Director and Chairman of the Executive Board of the DZNE.

Prof. Thomas Misgeld from the German Center for Neurodegenerative Diseases (DZNE) as well as the Technischen Universität München and Prof. Boris Schmidt, Technische Universität Darmstadt, have been awarded with the 2012 Hans and Ilse Breuer Foundation Alzheimer Research Award. The prize money totals 100,000 EUR and will be shared between the two scientists. The award ceremony took place on the 21st of November as part of the Eibsee Meeting “Cellular mechanisms of neurodegeneration”. “We congratulate Thomas Misgeld for receiving this prestigious award“, notes Prof. Pierluigi Nicotera, Scientific Director and Chairman of the Executive Board of the DZNE.2012-11-22T01:00:00+01:002012-11-22T01:00:00+01:00http://www.mdc-berlin.de/en/news/archive/2012/20121122-new_risk_factor_identified_for_high_blood_/index.htmlHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Preeclampsia is a serious complication of pregnancy and the major cause of death for both mother and child in Europe and the U.S. It affects about one in 20 pregnancies. The main symptoms are high blood pressure and protein in the urine. The cause of preeclampsia is still unclear. Dr. Florian Herse (Experimental and Clinical Research Center (ECRC) of the Max Delbrück Center (MDC) and the Charité), Dr. Ralf Dechend (ECRC and Helios Klinikum Berlin-Buch) and their collaborators have now identified an enzyme that is overexpressed in affected women and thus apparently contributes to development of the condition. In animal experiments, the researchers inhibited this enzyme and were able to ameliorate the disease process (10.1161/CIRCULATIONAHA.112.127340)*.

Preeclampsia is a serious complication of pregnancy and the major cause of death for both mother and child in Europe and the U.S. It affects about one in 20 pregnancies. The main symptoms are high blood pressure and protein in the urine. The cause of preeclampsia is still unclear. Dr. Florian Herse (Experimental and Clinical Research Center (ECRC) of the Max Delbrück Center (MDC) and the Charité), Dr. Ralf Dechend (ECRC and Helios Klinikum Berlin-Buch) and their collaborators have now identified an enzyme that is overexpressed in affected women and thus apparently contributes to development of the condition. In animal experiments, the researchers inhibited this enzyme and were able to ameliorate the disease process (10.1161/CIRCULATIONAHA.112.127340)*.2012-11-21T21:00:00+01:002012-11-21T21:00:00+01:00http://www.helmholtz-hzi.de/en/news_events/news/view/article/complete/six_patients_fall_ill_with_the_new_corona_virus/Helmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Update from 23 November 2012. Press information of the German Centre for Infection Research& On Friday, the World Health Organization (WHO) reported further cases of illness caused by the new corona virus; the number of laboratory-confirmed cases has thus risen to a total of six, four patients originating from Saudi Arabia and two from Qatar. Two of the four patients from Saudi Arabia have died. The two patients ...

Update from 23 November 2012. Press information of the German Centre for Infection Research& On Friday, the World Health Organization (WHO) reported further cases of illness caused by the new corona virus; the number of laboratory-confirmed cases has thus risen to a total of six, four patients originating from Saudi Arabia and two from Qatar. Two of the four patients from Saudi Arabia have died. The two patients ...2012-11-21T17:20:00+01:002012-11-21T17:20:00+01:00http://www.dlr.de/dlr/presse/en/desktopdefault.aspx/tabid-10172/213_read-5723/Helmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

On 20 and 21 November 2012, delegates from the 20 member states of the European Space Agency (ESA) and Canada met at the 'Mostra d'Oltremare' conference centre in Naples, Italy.

On 20 and 21 November 2012, delegates from the 20 member states of the European Space Agency (ESA) and Canada met at the 'Mostra d'Oltremare' conference centre in Naples, Italy.2012-11-21T15:39:43+01:002012-11-21T15:39:43+01:00http://www.hzg.de/cms01/public_relations/press_releases/034804/index_0034804.html.enHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Ferry boats in the service of science: On Sunday, 25/11/2012 you can watch a new video about the FerryBox in the cinema ?Lüneburger Scala-Programmkino? for the first time.

Ferry boats in the service of science: On Sunday, 25/11/2012 you can watch a new video about the FerryBox in the cinema ?Lüneburger Scala-Programmkino? for the first time.2012-11-21T15:36:49+01:002012-11-21T15:36:49+01:00http://www.hzg.de/cms01/public_relations/press_releases/034804/index_0034804.html.enHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Ferry boats in the service of science: On Sunday, 25/11/2012 you can watch a new video about the FerryBox in the cinema ?Lüneburger Scala-Programmkino? for the first time.

Ferry boats in the service of science: On Sunday, 25/11/2012 you can watch a new video about the FerryBox in the cinema ?Lüneburger Scala-Programmkino? for the first time.2012-11-21T02:12:11+01:002012-11-21T02:12:11+01:00http://www.kit.edu/visit/pi_2012_12249.phpHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

More than 300 million euros of third-party funding, 430 completed doctorates, 23700 students: These figures show that Karlsruhe Institute of Technology (KIT) continues to grow. The review of the year presented by KIT President Eberhard Umbach at the Annual Academic Celebration focused on recent successes of KIT scientists, future challenges as well as on the results of the Excellence Initiative.

More than 300 million euros of third-party funding, 430 completed doctorates, 23700 students: These figures show that Karlsruhe Institute of Technology (KIT) continues to grow. The review of the year presented by KIT President Eberhard Umbach at the Annual Academic Celebration focused on recent successes of KIT scientists, future challenges as well as on the results of the Excellence Initiative.2012-11-20T10:30:00+01:002012-11-20T10:30:00+01:00http://www.fz-juelich.de/SharedDocs/Pressemitteilungen/UK/EN/2012/12-11-20JuLab.htmlHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

School students from Ernst Mach Gymnasium in Hürth spent today at the JuLab schools laboratory to celebrate the first Helmholtz Day. The 25 schools laboratories in the Helmholtz Association, of which Forschungszentrum Jülich is also a member, have initiated this day to commemorate Hermann von Helmholtz (1821 - 1894). The Helmholtz Association takes its name from this leading 19th century scientist. From now on, Helmholtz Day will be celebrated once a year in November.

School students from Ernst Mach Gymnasium in Hürth spent today at the JuLab schools laboratory to celebrate the first Helmholtz Day. The 25 schools laboratories in the Helmholtz Association, of which Forschungszentrum Jülich is also a member, have initiated this day to commemorate Hermann von Helmholtz (1821 - 1894). The Helmholtz Association takes its name from this leading 19th century scientist. From now on, Helmholtz Day will be celebrated once a year in November.2012-11-19T01:00:00+01:002012-11-19T01:00:00+01:00http://www.mdc-berlin.de/en/news/2012/20121122-new_risk_factor_identified_for_high_blood_/index.htmlHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Preeclampsia is a serious complication of pregnancy and the major cause of death for both mother and child in Europe and the U.S. It affects about one in 20 pregnancies. The main symptoms are high blood pressure and protein in the urine. The cause of preeclampsia is still unclear. Dr. Florian Herse (Experimental and Clinical Research Center (ECRC) of the Max Delbrück Center (MDC) and the Charité), Dr. Ralf Dechend (ECRC and Helios Klinikum Berlin-Buch) and their collaborators have now identified an enzyme that is overexpressed in affected women and thus apparently contributes to development of the condition. In animal experiments, the researchers inhibited this enzyme and were able to ameliorate the disease process (10.1161/CIRCULATIONAHA.112.127340)*.

Preeclampsia is a serious complication of pregnancy and the major cause of death for both mother and child in Europe and the U.S. It affects about one in 20 pregnancies. The main symptoms are high blood pressure and protein in the urine. The cause of preeclampsia is still unclear. Dr. Florian Herse (Experimental and Clinical Research Center (ECRC) of the Max Delbrück Center (MDC) and the Charité), Dr. Ralf Dechend (ECRC and Helios Klinikum Berlin-Buch) and their collaborators have now identified an enzyme that is overexpressed in affected women and thus apparently contributes to development of the condition. In animal experiments, the researchers inhibited this enzyme and were able to ameliorate the disease process (10.1161/CIRCULATIONAHA.112.127340)*.2012-11-19T00:00:00+01:002012-11-19T00:00:00+01:00http://www.desy.de/information__services/press/pressreleases/@@news-view?id=4061&lang=engHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

With their ultra short X-ray flashes, free-electron lasers offer the opportunity to film chemical reactions or atoms in motion. However, for this super slow motion the arrival time and the temporal profile of the pulses must be precisely known. An international team of scientists has now developed a measurement technique that provides complete temporal characterization of individual FEL (free-electron laser) pulses at DESY´s soft-X-ray free-electron laser FLASH. The team, led by Adrian Cavalieri from the Center for Free-Electron Laser Science (CFEL) in Hamburg, was able to measure the temporal profile of each X-ray pulse with femtosecond precision (a femtosecond is a quadrillionth of a second). Their technique can be implemented at any of the world´s X-ray free-electron lasers, ultimately allowing for most effective utilization of these sources. The results are published in the current issue of the scientific journal “Nature Photonics”.

With their ultra short X-ray flashes, free-electron lasers offer the opportunity to film chemical reactions or atoms in motion. However, for this super slow motion the arrival time and the temporal profile of the pulses must be precisely known. An international team of scientists has now developed a measurement technique that provides complete temporal characterization of individual FEL (free-electron laser) pulses at DESY´s soft-X-ray free-electron laser FLASH. The team, led by Adrian Cavalieri from the Center for Free-Electron Laser Science (CFEL) in Hamburg, was able to measure the temporal profile of each X-ray pulse with femtosecond precision (a femtosecond is a quadrillionth of a second). Their technique can be implemented at any of the world´s X-ray free-electron lasers, ultimately allowing for most effective utilization of these sources. The results are published in the current issue of the scientific journal “Nature Photonics”.2012-11-16T15:09:00+01:002012-11-16T15:09:00+01:00http://www.dkfz.de/en/presse/pressemitteilungen/2012/dkfz-pm-12-58b-Science-and-industry-join-forces-to-optimize-cancer-treatment.phpHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Roche has concluded its first collaborative agreement on personalized healthcare with the National Center for Tumor Diseases (NCT), represented by its supporting institutions, the German Cancer Research Center (DKFZ) and Heidelberg University Hospital. The aim is to strengthen cooperation between all participating partners in the early stages of oncology research and development projects so that patients reap benefit from innovations sooner. Two projects are already underway. Joint press release of German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ), Roche, Heidelberg University Hospital (Universitätsklinikum Heidelberg) and National Center for Tumor Diseases (Nationales Centrum für Tumorerkrankungen, NCT)

Roche has concluded its first collaborative agreement on personalized healthcare with the National Center for Tumor Diseases (NCT), represented by its supporting institutions, the German Cancer Research Center (DKFZ) and Heidelberg University Hospital. The aim is to strengthen cooperation between all participating partners in the early stages of oncology research and development projects so that patients reap benefit from innovations sooner. Two projects are already underway. Joint press release of German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ), Roche, Heidelberg University Hospital (Universitätsklinikum Heidelberg) and National Center for Tumor Diseases (Nationales Centrum für Tumorerkrankungen, NCT)2012-11-15T10:00:00+01:002012-11-15T10:00:00+01:00http://www.helmholtz-hzi.de/en/news_events/news/view/article/complete/appetite_suppressant_for_scavenger_cells/Helmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

When infected with influenza, the body becomes an easy target for bacteria. The flu virus alters the host’s immune system and compromises its capacity to effectively fight off bacterial infections. Now, a team of immunologists at the Helmholtz Centre for Infection Research (HZI) and cooperation partners has discovered that an immune system molecule called TLR7 is partly to blame. The molecule recognizes the viral genome – and then signals scavenger cells of the immune system to ingest fewer bacteria. The researchers published their findings in the Journal of Innate Immunity.

When infected with influenza, the body becomes an easy target for bacteria. The flu virus alters the host’s immune system and compromises its capacity to effectively fight off bacterial infections. Now, a team of immunologists at the Helmholtz Centre for Infection Research (HZI) and cooperation partners has discovered that an immune system molecule called TLR7 is partly to blame. The molecule recognizes the viral genome – and then signals scavenger cells of the immune system to ingest fewer bacteria. The researchers published their findings in the Journal of Innate Immunity.2012-11-15T02:00:00+01:002012-11-15T02:00:00+01:00http://www.gfz-potsdam.de/portal/gfz/Public+Relations/Pressemitteilungen/aktuell/121115_Geothermie_BruesselHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Today in Brussels a workshop was held on the future role of geothermal energy in Europe's heat supply, initiated by the European Commission. The event "Future Utilization of Geothermal Energy in Urban Areas" concerning geothermal power and heat production in urban areas also featured the European Commissioner Günther H. Oettinger as a speaker. It was organized by two member centres of the Helmholtz Association, the Karlsruhe Institute of Technology (KIT) and the Helmholtz Centre Potsdam - GFZ German Research Centre for Geosciences.

Today in Brussels a workshop was held on the future role of geothermal energy in Europe's heat supply, initiated by the European Commission. The event "Future Utilization of Geothermal Energy in Urban Areas" concerning geothermal power and heat production in urban areas also featured the European Commissioner Günther H. Oettinger as a speaker. It was organized by two member centres of the Helmholtz Association, the Karlsruhe Institute of Technology (KIT) and the Helmholtz Centre Potsdam - GFZ German Research Centre for Geosciences.2012-11-15T00:00:00+01:002012-11-15T00:00:00+01:00http://www.helmholtz.de/en/press/press_releases/artikel/artikeldetail/chancen_der_nutzung_von_geothermie_in_staed_tischen_ballungsraeumen/Helmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

A workshop on the future role of geothermal energy in supplying heat in Europe took place in Brussels today on the initiative of the European Commission. The European Workshop on Future Utilization of Geothermal Energy in Urban Areas addressed the use of geothermal energy in generating heat and electricity in towns and cities and included a speech by EU Energy Commissioner Günther Oettinger. The event was organised by two Helmholtz Centres: the Karlsruhe Institute of Technology (KIT) and the Helmholtz Centre Potsdam ‒ German Research Centre for Geosciences (GFZ).

A workshop on the future role of geothermal energy in supplying heat in Europe took place in Brussels today on the initiative of the European Commission. The European Workshop on Future Utilization of Geothermal Energy in Urban Areas addressed the use of geothermal energy in generating heat and electricity in towns and cities and included a speech by EU Energy Commissioner Günther Oettinger. The event was organised by two Helmholtz Centres: the Karlsruhe Institute of Technology (KIT) and the Helmholtz Centre Potsdam ‒ German Research Centre for Geosciences (GFZ).2012-11-14T01:00:00+01:002012-11-14T01:00:00+01:00http://www.ufz.de/index.php?en=30928Helmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Environmental contaminants, such as smoking, are harmful to the human organism in relation to the occurrence of allergies. This is known. Until now, researchers had never investigated whether and to what extent environmental contaminants also affect allergy-relevant stem cells. For the first time a team at the Helmholtz Centre for Environmental Research (UFZ) has found evidence for this: Smoking affects the development of peripheral allergy-relevant stem cells in the blood. In order to present this result Dr. Irina Lehmann and Dr. Kristin Weiße chose a new scientific path: The combination of exposure analysis and stem cell research.

Environmental contaminants, such as smoking, are harmful to the human organism in relation to the occurrence of allergies. This is known. Until now, researchers had never investigated whether and to what extent environmental contaminants also affect allergy-relevant stem cells. For the first time a team at the Helmholtz Centre for Environmental Research (UFZ) has found evidence for this: Smoking affects the development of peripheral allergy-relevant stem cells in the blood. In order to present this result Dr. Irina Lehmann and Dr. Kristin Weiße chose a new scientific path: The combination of exposure analysis and stem cell research.2012-11-13T17:24:43+01:002012-11-13T17:24:43+01:00http://www.fz-juelich.de/SharedDocs/Pressemitteilungen/UK/EN/2012/12-11-13fusion.htmlHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

The new building for plasma physics at Forschungszentrum Jülich was officially opened today by representatives from politics and science. Jülich scientists working in this field are involved in coordinated efforts worldwide to create power plants based on nuclear fusion. The new building, constructed at a cost of € 4.6 million, provides office space and additional laboratory facilities.

The new building for plasma physics at Forschungszentrum Jülich was officially opened today by representatives from politics and science. Jülich scientists working in this field are involved in coordinated efforts worldwide to create power plants based on nuclear fusion. The new building, constructed at a cost of € 4.6 million, provides office space and additional laboratory facilities.2012-11-13T15:20:00+01:002012-11-13T15:20:00+01:00http://www.dkfz.de/en/presse/pressemitteilungen/2012/dkfz-pm-12-58-Disrupted-Signaling-and-Disease.phpHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Scientists from around the globe will convene at the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) on November 15th – 16th, 2012 to discuss the links between a disrupted metabolism and various diseases. The conference “Metabolism 2012: From Signaling to Disease” is part of an annual forum series organized in Heidelberg by the DKFZ-ZMBH Alliance, which is a strategic alliance between the German Cancer Research Center (DKFZ) and the Center for Molecular Biology (ZMBH) at Heidelberg University. Professor Stephan Herzig, who heads a joint research department of DKFZ, ZMBH and Heidelberg University Hospital on diabetes and cancer, leads conference organization.

Scientists from around the globe will convene at the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) on November 15th – 16th, 2012 to discuss the links between a disrupted metabolism and various diseases. The conference “Metabolism 2012: From Signaling to Disease” is part of an annual forum series organized in Heidelberg by the DKFZ-ZMBH Alliance, which is a strategic alliance between the German Cancer Research Center (DKFZ) and the Center for Molecular Biology (ZMBH) at Heidelberg University. Professor Stephan Herzig, who heads a joint research department of DKFZ, ZMBH and Heidelberg University Hospital on diabetes and cancer, leads conference organization.2012-11-13T14:39:41+01:002012-11-13T14:39:41+01:00http://www.fz-juelich.de/SharedDocs/Pressemitteilungen/UK/EN/2012/12-11-12Thermische_Fluktuationen.htmlHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

At what pressure do thin shells start to collapse? This classical mechanical problem also plays a part in understanding microcapsules, which are used to transport active ingredients directly to an organ in the body. In contrast to pressure vessels or diving bells, thermal fluctuations also exert an influence here. The microscopic shells are deformed in an uncontrolled manner due to this thermally induced molecular motion. Under pressure, these shells therefore tend to collapse at an earlier stage than predicted, which was revealed for the first time in precise calculations made by Jülich scientists and their partners from Harvard University. Their findings have been published in the renowned journal PNAS.

At what pressure do thin shells start to collapse? This classical mechanical problem also plays a part in understanding microcapsules, which are used to transport active ingredients directly to an organ in the body. In contrast to pressure vessels or diving bells, thermal fluctuations also exert an influence here. The microscopic shells are deformed in an uncontrolled manner due to this thermally induced molecular motion. Under pressure, these shells therefore tend to collapse at an earlier stage than predicted, which was revealed for the first time in precise calculations made by Jülich scientists and their partners from Harvard University. Their findings have been published in the renowned journal PNAS.2012-11-12T15:07:00+01:002012-11-12T15:07:00+01:00http://www.dkfz.de/en/presse/pressemitteilungen/2012/dkfz-pm-57-Searching-for-Defects-in-Cancer-Cell-Genomes.phpHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

An interdisciplinary German research network with major participation of researchers from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) has sequenced the complete genome of Burkitt lymphoma cancer cells. In their project as part of the International Cancer Genome Consortium (ICGC), the scientists found the genome of Burkitt lymphoma tumor cells mutated in more than 2,000 spots compared to normal cells. The researchers discovered a gene mutated in more than three thirds of all Burkitt lymphomas. This provides new targets for diagnosis and therapy of this aggressive type of lymphoma. The giant amount of data generated in this project is stored and evaluated at DKFZ, where Prof. Roland Eils has been building up a bioinformatics infrastructure for cancer genome sequencing unique in Germany. The results have now been published in the journal Nature Genetics.

An interdisciplinary German research network with major participation of researchers from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) has sequenced the complete genome of Burkitt lymphoma cancer cells. In their project as part of the International Cancer Genome Consortium (ICGC), the scientists found the genome of Burkitt lymphoma tumor cells mutated in more than 2,000 spots compared to normal cells. The researchers discovered a gene mutated in more than three thirds of all Burkitt lymphomas. This provides new targets for diagnosis and therapy of this aggressive type of lymphoma. The giant amount of data generated in this project is stored and evaluated at DKFZ, where Prof. Roland Eils has been building up a bioinformatics infrastructure for cancer genome sequencing unique in Germany. The results have now been published in the journal Nature Genetics.2012-11-12T15:00:00+01:002012-11-12T15:00:00+01:00http://www.fz-juelich.de/SharedDocs/Pressemitteilungen/UK/EN/2012/12-11-12juqueen.htmlHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

The new high performance Computer JUQUEEN at Forschungszentrum Juelich has reached the new top position as Europe's fastest supercomputer and 5th fastest in the world by the current TOP500 List, published recently. As the first supercomputer in Europe to reach a compute performance of 5 Petaflop/s – equating to 5 quadrillion operations per second – the system opens up new possibilities for research intensive grand projects and a wider spectrum of participating work groups.

The new high performance Computer JUQUEEN at Forschungszentrum Juelich has reached the new top position as Europe's fastest supercomputer and 5th fastest in the world by the current TOP500 List, published recently. As the first supercomputer in Europe to reach a compute performance of 5 Petaflop/s – equating to 5 quadrillion operations per second – the system opens up new possibilities for research intensive grand projects and a wider spectrum of participating work groups.2012-11-11T00:00:00+01:002012-11-11T00:00:00+01:00http://www.desy.de/information__services/press/pressreleases/@@news-view?id=3981&lang=engHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Using the world’s most powerful X-ray laser in California, an international research team discovered a surprising behaviour of atoms: with a single X-ray flash, the group led by Daniel Rolles from the Center for Free-Electron Laser Science (CFEL) in Hamburg (Germany) was able to kick a record number of 36 electrons at once out of a xenon atom. According to theoretical calculations, these are significantly more than should be possible at this energy of the X-ray radiation. The team present their unexpected observations in the journal “Nature Photonics”. CFEL is a collaboration of DESY, the Max Planck Society and the University of Hamburg.

Using the world’s most powerful X-ray laser in California, an international research team discovered a surprising behaviour of atoms: with a single X-ray flash, the group led by Daniel Rolles from the Center for Free-Electron Laser Science (CFEL) in Hamburg (Germany) was able to kick a record number of 36 electrons at once out of a xenon atom. According to theoretical calculations, these are significantly more than should be possible at this energy of the X-ray radiation. The team present their unexpected observations in the journal “Nature Photonics”. CFEL is a collaboration of DESY, the Max Planck Society and the University of Hamburg.2012-11-09T09:27:31+01:002012-11-09T09:27:31+01:00http://www.hzg.de/cms01/public_relations/press_releases/034606/index_0034606.html.enHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

The Institute of Polymer Research at the Helmholtz-Zentrum Geesthacht organises a workshop for scientists in industry and at universities on November 13th and 14th. An introduction into the mechanical and rheological properties of polymer materials and an extensive insight into the application methods of the rheology and mechanics of polymers in practice will be presented by experts from industry and research.

The Institute of Polymer Research at the Helmholtz-Zentrum Geesthacht organises a workshop for scientists in industry and at universities on November 13th and 14th. An introduction into the mechanical and rheological properties of polymer materials and an extensive insight into the application methods of the rheology and mechanics of polymers in practice will be presented by experts from industry and research.2012-11-09T00:00:00+01:002012-11-09T00:00:00+01:00http://www.helmholtz-hzi.de/en/news_events/news/view/article/complete/a_finger_pointing_the_way_to_new_hepatitis_c_medication/Helmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Some 160 million men and women are infected with hepatitis C virus (HCV), the most common cause of cirrhosis and cancer of the liver. The present standard therapy is thraught with serious side-effects leading to a cure in only half of the patients. New therapies utilise small molecules that inhibit specific steps in the viral reproduction. However, the pathogen rapidly develops resistance, becoming insensitive to these agents. Researchers at the Helmholtz Centre for Infection Research (HZI) in Braunschweig, in collaboration with colleagues from the TWINCORE in Hannover have discovered new drug leads that are also efficient against resistant virus. They present their work in the "Journal of Biological Chemistry".

Some 160 million men and women are infected with hepatitis C virus (HCV), the most common cause of cirrhosis and cancer of the liver. The present standard therapy is thraught with serious side-effects leading to a cure in only half of the patients. New therapies utilise small molecules that inhibit specific steps in the viral reproduction. However, the pathogen rapidly develops resistance, becoming insensitive to these agents. Researchers at the Helmholtz Centre for Infection Research (HZI) in Braunschweig, in collaboration with colleagues from the TWINCORE in Hannover have discovered new drug leads that are also efficient against resistant virus. They present their work in the "Journal of Biological Chemistry".2012-11-08T00:00:00+01:002012-11-08T00:00:00+01:00http://www.dzne.de/en/about-us/public-relations/meldungen/2012/press-release-no-24.htmlHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

The feel-good hormone dopamine improves long-term memory. This is the finding of a team lead by Emrah Düzel, neuroscientist at the German Center for Neurodegenerative Diseases (DZNE) and the University of Magdeburg. The researchers investigated test subjects ranging in age from 65 to 75 years, who were given a precursor of dopamine. Treated subjects performed better in a memory test than a comparison group, who had taken a placebo. The study provides new insights into the formation of long lasting memories and also has implications for understanding why memories fade more rapidly following the onset of Alzheimer’s disease. The results appear in the “Journal of Neuroscience”.

The feel-good hormone dopamine improves long-term memory. This is the finding of a team lead by Emrah Düzel, neuroscientist at the German Center for Neurodegenerative Diseases (DZNE) and the University of Magdeburg. The researchers investigated test subjects ranging in age from 65 to 75 years, who were given a precursor of dopamine. Treated subjects performed better in a memory test than a comparison group, who had taken a placebo. The study provides new insights into the formation of long lasting memories and also has implications for understanding why memories fade more rapidly following the onset of Alzheimer’s disease. The results appear in the “Journal of Neuroscience”.2012-11-06T15:37:12+01:002012-11-06T15:37:12+01:00http://www.hzg.de/cms01/public_relations/press_releases/034598/index_0034598.html.enHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Innovative ideas "made in Schleswig-Holstein" were awarded on Thursday, 1st of November in the German National Library of Economics (ZBW) in Kiel. The 1000 Euro special award "nanotechnology" was received to the Geesthacht polymer researcher Prof. Dr.-Ing. Mady Elbahri.

Innovative ideas "made in Schleswig-Holstein" were awarded on Thursday, 1st of November in the German National Library of Economics (ZBW) in Kiel. The 1000 Euro special award "nanotechnology" was received to the Geesthacht polymer researcher Prof. Dr.-Ing. Mady Elbahri.2012-11-06T01:00:00+01:002012-11-06T01:00:00+01:00http://www.mdc-berlin.de/en/news/2012/20121106-prof__walter_rosenthal___the_founding_of_t/index.htmlHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

“The founding of the Berlin Institute of Health, (BIH) is a unique opportunity for the German science landscape to restructure the collaboration between a non-university research institution and a university medical center in the field of basic and clinical research,” said Prof. Walter Rosenthal, chairman of the board and scientific director of the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch. Speaking at a press conference with Federal Research Minister Annette Schavan and Berlin’s Governing Mayor Klaus Wowereit in the Charité on November 6, 2012, he went on to say: “For politicians, German reunification was something unique, just as it was for me as a citizen. Something like that only happens once in a lifetime. And here in the field of science another once-in-a-lifetime opportunity has presented itself – to participate in the creation of an entirely new research structure. I am therefore delighted that we can be part of the founding of the BIH.

“The founding of the Berlin Institute of Health, (BIH) is a unique opportunity for the German science landscape to restructure the collaboration between a non-university research institution and a university medical center in the field of basic and clinical research,” said Prof. Walter Rosenthal, chairman of the board and scientific director of the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch. Speaking at a press conference with Federal Research Minister Annette Schavan and Berlin’s Governing Mayor Klaus Wowereit in the Charité on November 6, 2012, he went on to say: “For politicians, German reunification was something unique, just as it was for me as a citizen. Something like that only happens once in a lifetime. And here in the field of science another once-in-a-lifetime opportunity has presented itself – to participate in the creation of an entirely new research structure. I am therefore delighted that we can be part of the founding of the BIH.2012-11-06T01:00:00+01:002012-11-06T01:00:00+01:00http://www.mdc-berlin.de/en/news/archive/2012/20121106-prof__walter_rosenthal___the_founding_of_t/index.htmlHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

“The founding of the Berlin Institute of Health, (BIH) is a unique opportunity for the German science landscape to restructure the collaboration between a non-university research institution and a university medical center in the field of basic and clinical research,” said Prof. Walter Rosenthal, chairman of the board and scientific director of the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch. Speaking at a press conference with Federal Research Minister Annette Schavan and Berlin’s Governing Mayor Klaus Wowereit in the Charité on November 6, 2012, he went on to say: “For politicians, German reunification was something unique, just as it was for me as a citizen. Something like that only happens once in a lifetime. And here in the field of science another once-in-a-lifetime opportunity has presented itself – to participate in the creation of an entirely new research structure. I am therefore delighted that we can be part of the founding of the BIH.

“The founding of the Berlin Institute of Health, (BIH) is a unique opportunity for the German science landscape to restructure the collaboration between a non-university research institution and a university medical center in the field of basic and clinical research,” said Prof. Walter Rosenthal, chairman of the board and scientific director of the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch. Speaking at a press conference with Federal Research Minister Annette Schavan and Berlin’s Governing Mayor Klaus Wowereit in the Charité on November 6, 2012, he went on to say: “For politicians, German reunification was something unique, just as it was for me as a citizen. Something like that only happens once in a lifetime. And here in the field of science another once-in-a-lifetime opportunity has presented itself – to participate in the creation of an entirely new research structure. I am therefore delighted that we can be part of the founding of the BIH.2012-11-06T00:00:00+01:002012-11-06T00:00:00+01:00http://www.helmholtz.de/en/press/press_releases/artikel/artikeldetail/max_delbrueck_centrum_und_charite_vereinen_forschungsaktivitaeten/Helmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

The Federal Minister of Education and Research, Prof. Annette Schavan, announced today in the presence of the Governing Mayor of Berlin, Klaus Wowereit, that researchers at the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch, a member of the Helmholtz Association, and the Charité – Universitätsmedizin Berlin will be working together under one roof in the future. The Helmholtz Association regards this fusion of two top-level research institutes as a major step forward in the future development of the German research system.

The Federal Minister of Education and Research, Prof. Annette Schavan, announced today in the presence of the Governing Mayor of Berlin, Klaus Wowereit, that researchers at the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch, a member of the Helmholtz Association, and the Charité – Universitätsmedizin Berlin will be working together under one roof in the future. The Helmholtz Association regards this fusion of two top-level research institutes as a major step forward in the future development of the German research system.2012-11-05T09:50:00+01:002012-11-05T09:50:00+01:00http://www.dkfz.de/en/presse/pressemitteilungen/2012/dkfz-pm-12-56-Scientists-Find-Achilles-Heel-of-Cancer-Cells.phpHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Scientists from the German Cancer Research Center (Deutsches Krebsforschungszentrum) and Heidelberg University Hospital have identified the HDAC11 enzyme as a promising target for new cancer therapies. If this molecule is turned off, cancer cells stop growing and die. Normal cells, however, are not affected by blocking HDAC11. The researchers are now looking for compounds that block selectively HDAC11.

Scientists from the German Cancer Research Center (Deutsches Krebsforschungszentrum) and Heidelberg University Hospital have identified the HDAC11 enzyme as a promising target for new cancer therapies. If this molecule is turned off, cancer cells stop growing and die. Normal cells, however, are not affected by blocking HDAC11. The researchers are now looking for compounds that block selectively HDAC11.2012-11-02T11:08:57+01:002012-11-02T11:08:57+01:00http://www.kit.edu/visit/pi_2012_12209.phpHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

The Chinese Nanjing University of Science and Technology is establishing a nanoscience institute using the Institute of Na-notechnology (INT) of Karlsruhe Institute of Technology (KIT) as a model. The new institute is named after and will be headed by Professor Herbert Gleiter. The co-founder and former director of INT, where he is still conducting research, is a pioneer of nanosciences worldwide. At the Herbert Gleiter Institute of Nanoscience, five research groups will be established, of which four will be headed by leading INT nanoscientists.

The Chinese Nanjing University of Science and Technology is establishing a nanoscience institute using the Institute of Na-notechnology (INT) of Karlsruhe Institute of Technology (KIT) as a model. The new institute is named after and will be headed by Professor Herbert Gleiter. The co-founder and former director of INT, where he is still conducting research, is a pioneer of nanosciences worldwide. At the Herbert Gleiter Institute of Nanoscience, five research groups will be established, of which four will be headed by leading INT nanoscientists.2012-11-02T10:14:03+01:002012-11-02T10:14:03+01:00http://www.awi.de/en/news/press_releases/detail/item/geowissenschaftlerin_dr_juliane_mueller_erhaelt_den_deutschen_studienpreis_fuer_ihre_wegweisende_kl/?cHash=b5d1433288dc5f28783aa23f14550a5eHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Dr Juliane Müller will be awarded a second place in the German Study Prize on 6 November in Berlin. The Körber Foundation honours the geoscientist from the Alfred Wegener Institute for Polar and Marine Research in the Helmholtz Association for her pioneering PhD thesis on sea ice distribution.

Dr Juliane Müller will be awarded a second place in the German Study Prize on 6 November in Berlin. The Körber Foundation honours the geoscientist from the Alfred Wegener Institute for Polar and Marine Research in the Helmholtz Association for her pioneering PhD thesis on sea ice distribution.2012-11-02T01:00:00+01:002012-11-02T01:00:00+01:00http://www.mdc-berlin.de/en/news/archive/2012/20121102-new_findings_on_gene_regulation_and_bone_d1/index.htmlHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

  The patients have single short fingers (metacarpals) and toes (metatarsals) and can be restricted in growth due to a shortened skeleton. This hereditary disease is called brachydactyly type E (Greek for short fingers). Three years ago Dr. Philipp G. Maass from the research group of Professor Friedrich C. Luft at the Experimental and Clinical Research Center (ECRC), a joint cooperation between the Charité Medical Faculty and the Max Delbrück Center for Molecular Medicine (MDC) in Berlin-Buch, has discovered an epigenetic mechanism, which, when dysregulated, causes this condition. Now, together with Dr. Sylvia Bähring (ECRC) he was able to show how this epigenetic regulator functions and influences the development of the skeleton and the extremities. Also, he shed light on a new principle of gene regulation (Journal of Clinical Investigation, doi: 10.1172/JCI65508)*.

  The patients have single short fingers (metacarpals) and toes (metatarsals) and can be restricted in growth due to a shortened skeleton. This hereditary disease is called brachydactyly type E (Greek for short fingers). Three years ago Dr. Philipp G. Maass from the research group of Professor Friedrich C. Luft at the Experimental and Clinical Research Center (ECRC), a joint cooperation between the Charité Medical Faculty and the Max Delbrück Center for Molecular Medicine (MDC) in Berlin-Buch, has discovered an epigenetic mechanism, which, when dysregulated, causes this condition. Now, together with Dr. Sylvia Bähring (ECRC) he was able to show how this epigenetic regulator functions and influences the development of the skeleton and the extremities. Also, he shed light on a new principle of gene regulation (Journal of Clinical Investigation, doi: 10.1172/JCI65508)*.2012-10-31T00:00:00+01:002012-10-31T00:00:00+01:00http://www.helmholtz.de/en/press/press_releases/artikel/artikeldetail/kooperation_mit_oman_gestaerkt/Helmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Representatives of the Helmholtz Association and The Research Council (TRC), Oman’s research funding body, signed an agreement in Berlin last night in which they reiterated their plans to build a technology centre in Oman. Research at the new institute will focus on improved oil and gas extraction, water resources technology and renewable energies. Four Helmholtz centres are involved in this cooperation so far: GEOMAR Helmholtz Centre for Ocean Research Kiel, the Helmholtz Centre Potsdam ‒ German Research Centre for Geosciences (GFZ), the Helmholtz Centre for Environmental Research - UFZ and the German Aerospace Center (DLR).

Representatives of the Helmholtz Association and The Research Council (TRC), Oman’s research funding body, signed an agreement in Berlin last night in which they reiterated their plans to build a technology centre in Oman. Research at the new institute will focus on improved oil and gas extraction, water resources technology and renewable energies. Four Helmholtz centres are involved in this cooperation so far: GEOMAR Helmholtz Centre for Ocean Research Kiel, the Helmholtz Centre Potsdam ‒ German Research Centre for Geosciences (GFZ), the Helmholtz Centre for Environmental Research - UFZ and the German Aerospace Center (DLR).2012-10-30T14:49:00+01:002012-10-30T14:49:00+01:00http://www.dkfz.de/en/presse/pressemitteilungen/2012/dkfz-pm-12-55-Tumor-Analysis-in-Cerebrospinal-Fluid.phpHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Researchers from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) plan to develop a technique that will enable them to detect pediatric brain tumors in cerebrospinal fluid. The biology and extent of the cancers – both decisive factors in determining therapeutic choices – will also be assessed using this method. The James S. McDonnell Foundation will provide funds of almost half a million US dollars to support the project led by Professor Dr. Stefan Pfister.

Researchers from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) plan to develop a technique that will enable them to detect pediatric brain tumors in cerebrospinal fluid. The biology and extent of the cancers – both decisive factors in determining therapeutic choices – will also be assessed using this method. The James S. McDonnell Foundation will provide funds of almost half a million US dollars to support the project led by Professor Dr. Stefan Pfister.2012-10-30T00:00:00+01:002012-10-30T00:00:00+01:00http://www.hzdr.de/db/Cms?pNid=99&pOid=37858Helmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Ein neues internationales Forum für den Austausch zwischen experimenteller und theoretischer Forschung auf dem Gebiet radioaktiver Schwermetalle (Aktinide) findet vom 5. bis 7. November 2012 am HZDR statt.

Ein neues internationales Forum für den Austausch zwischen experimenteller und theoretischer Forschung auf dem Gebiet radioaktiver Schwermetalle (Aktinide) findet vom 5. bis 7. November 2012 am HZDR statt.2012-10-29T14:28:00+01:002012-10-29T14:28:00+01:00http://www.dkfz.de/en/presse/pressemitteilungen/2012/dkfz-pm-12-54-Nationwide-Alliance-Against-Cancer.phpHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

With the attendance of Germany´s Federal Minister Professor Dr. Annette Schavan and State Minister Theresia Bauer, the official launch of the German Consortium for Translational Cancer Research (DKTK) was celebrated today in Heidelberg.

With the attendance of Germany´s Federal Minister Professor Dr. Annette Schavan and State Minister Theresia Bauer, the official launch of the German Consortium for Translational Cancer Research (DKTK) was celebrated today in Heidelberg.2012-10-26T09:13:32+02:002012-10-26T09:13:32+02:00http://www.awi.de/en/news/press_releases/detail/item/winter_experiment_in_antarctic_sea_ice_planned/?cHash=432a0ddcaadc4e31a288cbe19f4d52a4Helmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

The research ship POLARSTERN sets off in the early morning hours of 27 October 2012 for an unusual expedition to the Antarctic. This time the ship will not be returning to Bremerhaven as usual at the end of the Antarctic summer, but will be spending the winter in the South Polar Sea for research purposes.

The research ship POLARSTERN sets off in the early morning hours of 27 October 2012 for an unusual expedition to the Antarctic. This time the ship will not be returning to Bremerhaven as usual at the end of the Antarctic summer, but will be spending the winter in the South Polar Sea for research purposes.2012-10-26T08:55:30+02:002012-10-26T08:55:30+02:00http://www.hzg.de/cms01/public_relations/press_releases/034437/index_0034437.html.enHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Is a paradigm shift imminent in the field of implant materials? Scientists at the Helmholtz Zentrum Geesthacht are engaged in research on biodegradable magnesium biomaterials which can be used as bone replacements in medical applications. They will present their research results from the 1st to 3rd November at the annual congress of the DGBM (German society for Biomaterials) in Hamburg.

Is a paradigm shift imminent in the field of implant materials? Scientists at the Helmholtz Zentrum Geesthacht are engaged in research on biodegradable magnesium biomaterials which can be used as bone replacements in medical applications. They will present their research results from the 1st to 3rd November at the annual congress of the DGBM (German society for Biomaterials) in Hamburg.2012-10-26T02:00:00+02:002012-10-26T02:00:00+02:00http://www.ufz.de/index.php?en=30926Helmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

Researchers from Germany and Slovakia have pointed out that the chemical triclosan is one of those particularly harmful substances for the ecological status of rivers that are still not sufficiently monitored. With extensive monitoring conducted in the Elbe river basin that was more comprehensive than standard monitoring procedures, concentrations of the chemical at numerous test sites exceeded the predicted no-effect concentration (PNEC) for algal communities up to a factor of twelve. From the 500 river basin-specific pollutants investigated, triclosan (normally used as an anti-bacterial agent) ranked sixth as one of the most particularly harmful substances in Europe. It is therefore imperative to include this substance in routine monitoring programmes at the European scale, according to what researchers from the Helmholtz Centre for Environmental Research (UFZ) and the Environmental Institute in Slovakia have written in the journal „Environmental Science Pollution Research“.

Researchers from Germany and Slovakia have pointed out that the chemical triclosan is one of those particularly harmful substances for the ecological status of rivers that are still not sufficiently monitored. With extensive monitoring conducted in the Elbe river basin that was more comprehensive than standard monitoring procedures, concentrations of the chemical at numerous test sites exceeded the predicted no-effect concentration (PNEC) for algal communities up to a factor of twelve. From the 500 river basin-specific pollutants investigated, triclosan (normally used as an anti-bacterial agent) ranked sixth as one of the most particularly harmful substances in Europe. It is therefore imperative to include this substance in routine monitoring programmes at the European scale, according to what researchers from the Helmholtz Centre for Environmental Research (UFZ) and the Environmental Institute in Slovakia have written in the journal „Environmental Science Pollution Research“.2012-10-25T11:53:00+02:002012-10-25T11:53:00+02:00http://www.dkfz.de/en/presse/pressemitteilungen/2012/dkfz-pm-2012-7-5-Million-Euros-for-the-Fight-Against-Cancer.phpHelmholtz-Gemeinschaftonline@helmholtz.de© Helmholtz-Gemeinschaft

The Dietmar Hopp Foundation will fund the Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM) at the German Cancer Research Center (DKFZ) for another five years.

The Dietmar Hopp Foundation will fund the Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM) at the German Cancer Research Center (DKFZ) for another five years.